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Abstract 
Mutants of RTEM-1 B-lactamase, an enzyme responsible for 
bacterial resistance to B-lactam antibiotics, have been 
constructed by cassette mutagenesis. B-Lactamases have been 
classified into three groups based on catalytic and struc-
tural similarities. Class A B-lactamases, of which the RTEM-
1 enzyme is a member, maintain a conserved triad of amino 
acids about the active site serine, Ser-Thr-X-Lys, where X is 
not conserved. Endonuclease restriction sites flanking the 
codons of the active site residues were used to remove the 
portion of the B-lactamase gene coding for the wild-type 
active site sequence. A duplex strand of synthetic oligo-
nucleotides spanning the removed region of the gene and 
coding for the desired mutations was ligated in place of the 
wild-type sequence. Subsequent chemical sequencing of the 
mutated plasmids by the Maxam-Gilbert technique confirmed the 
presence of the mutations. 
A mutant converting Thr71 to cysteine, designated Thr71 
-->Cys, was constructed and shown to impart to cells a 
phenotype resistant to high levels of ampicillin (>350 mg/L). 
Purification of the mutant to homogeneity was accomplished 
using plasmid pJN which contains the B-lactamase gene under 
control of the tac promoter and the gene for kanamycin resis-
tance. Cells were grown at 37°C and induction was carried 
out at 30°C to reduce protein losses due to the thermal in-
iv 
stability of the mutant. The Thr71-->Cys mutant retains 12% 
of the efficiency of the wild-type enzyme on benzylpenicillin 
3% on cephalothin, and 9% on 6-aminopenicillanic acid. The 
mutant has an altered pH activity profile, with activity 
declining more rapidly at alkaline pH than for the wild-type 
enzyme. The mutant is susceptible to inactivation by the 
sulfhydryl reagent pCMB under conditions where the activity 
of the wild-type enzyme is not affected. The mutant is 
inhibited competitively by borate ion. The Thr71-->Cys 
mutant is less stable to thermal denaturation than the wild-
type enzyme, as are all other mutants at position 71. 
The conserved lysine at position 73 of B-lactamase was 
replaced with all other amino acids and an amber stop codon 
by cassette mutagenesis using synthetic oligonucleotides con-
taining a mixture of bases in place of the lysine codon. Af-
ter ligation the mixtures of plasmids were used to transform 
~ coli to tetracycline resistance. Plasmids derived from 
one hundred colonies were sequenced by the Maxam-Gilbert 
method. Because of an uneven mixture of bases in the mixed 
codon not all twenty amino acids were located in the first 
one hundred colonies. Mutants Lys73-->Asp, Glu and Pro were 
constructed separately using the same three fragment ligation 
scheme. None of the mutants at position 73 were able to con-
fer to cells a phenotype resistant to even low levels of am-
picillin. Western blot analysis of whole cell extracts 
revealed mutants with all nineteen amino acid replacements 
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present in amounts not significantly different from the 
amount of the wild-type enzyme. 
Purification of mutants Lys73-->Arg and Cys was accom-
plished with the use of plasmid pJN and the tac promoter. 
Kinetic analysis revealed both mutants maintain 0.01% of the 
activity of the wild-type enzyme on benzylpenicillin. The 
Michaelis constant, KM, was not significantly different from 
the value of the wild-type. The Lys73-->Cys mutant was 
slightly less stable to thermal denaturation than the wild-
type enzyme. The pH-activity profile of the. Lys73-->Cys 
mutant showed a maximum at pH 8.3 while the wild-type 
activity is maximal at pH 6.5. Treatment of the Lys73-->Cys 
mutant with ethylenimine, which converts cysteine to amino-
ethylcysteine, under mildly denaturing conditions resulted in 
a dramatic increase in specific activity of the mutant. 
Purification of the derivatized mutant by anion exchange on 
FPLC and kinetic analysis showed the derivatized mutant 
regained 62% of the catalytic efficiency of the wild-type 
enzyme. 
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Nomenclature 
The numbering system for B-lactamase is that proposed by 
Ambler, (1980) Phil. Trans. Roy. Soc. London Ser. B 289, 321-
331. 
Expressions of the form, Lys73-->Cys, indicate a mutant 
in which the lysine residue at position 73 has been replaced 
by cysteine. Expressions of the form, pBR322K71C, indicate a 
plasmid in which the codon for the amino acid at the 73rd 
position of the protein, originally the codon for lysine, has 
been replaced by the codon for cysteine. The one letter 
notation used is the one recommended by the IUPAC-IUB Com-
mission on Biochemical Nomenclature: A, alanine; c, cysteine; 
D, aspartic acid; E, glutamic acid; F, phenylalanine; G, 
glycine; H, histidine; I, isoleucine; K, lysine; L, leucine; 
M, methionine; N, asparagine; P, proline; Q, glutamine; R, 
arginine; s, serine; T, threonine; V, valine; W, tryptophan; 
Y, tyrosine. 
Abbreviations: 
IPTG, isopropylthiogalactopuranoside; bp, basepairs; TetR, 
tetracycline resistant; AmpR, ampicillin resistant; pCMB, 




Applications of Oligonucleotide-directed 
Mutagenesis 
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The linear sequence of amino acids composing a protein 
determines the protein's three dimensional structure. The 
structure of a protein dictates its catalytic function. The 
contribution of individual amino acids to the overall struc-
ture and thus to the function of a protein is a subject of 
extreme importance and one that is currently under investig-
ation in a wide variety of biochemical systems. Perturba-
tions of the amino acid sequence by single site substitutions 
is one approach to assessing the importance of individual 
amino acid residues to the structure and function of an en-
zyme. 
Studies of the relationship between the structure of a 
protein and its function have been greatly facilitated by the 
development of oligonucleotide-directed mutagenic techniques. 
These techniques allow the change of one or more specific 
amino acids of a protein to any other amino acid, a helpful 
addition to the classical method for obtaining mutants which 
consisted of screening for spontaneous variations in pheno-
type, and also of increasing the rate of variation by random 
mutagenesis. Differences in the functions of the wild-type 
and mutated proteins are attributed to the difference in the 
amino acid being studied. Thus, the role of a particular 
residue in a protein may be inferred by the study of one or 
more mutants at that site (for recent reviews see (1) and 
( 2) ) • 
Several general techniques have been developed for the 
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creation of site-specific mutations. The most widely used 
method involves a single-strand vector, generally M13 phage 
(3). Briefly, the part of the gene coding for the protein of 
interest and containing the site to be mutated is subcloned 
into one of the M13 cloning vehicles. Single strand phage 
DNA (ssDNA) is isolated. An oligonucleotide primer, typi-
cally 12 to 20 bases, containing one or two mismatches cre-
ating the mutation, is annealed to the ssDNA and the large 
(Klenow) fragment of DNA polymerase I is added and DNA poly-
merization is carried out. This gives rise to the double 
stranded, replicative form (RF) of the phage DNA which is 
used to transfect ~ coli. The resulting plaques are 
screened for the presence of the mutated gene by one of sev-
eral methods. The most widely used method involves screening 
by hybridization to the radioactive oligonucleotide primer. 
The melting temperature of the primer annealed to the mutated 
sequence will be distinguishably higher than that of primer 
annealed to the original, mismatched sequence. Putative mu-
tations thus identified may be confirmed by DNA sequencing. 
Improvements designed to increase the frequency of mutation 
have been reported (4-7), and summarized (8,9). 
Another, similar method requires the gene of interest be 
located on a double stranded vector (10,11). Generally, 
double-stranded vectors are the usual expression system and 
can reduce the frequency of unwanted, secondary mutations ob-
served with single-stranded vectors (12). These methods in-
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volve nicking the double-stranded vector with a restriction 
endonuclease or DNAse I at a site adjacent to the site to be 
mutated. The nicked circles are subjected to exonuclease 
digestion to create gapped duplexes. The mutagenic oligonuc-
leotide is annealed and polymerization carried out. Trans-
formation and screening are performed in a manner analogous 
to that for Ml3 mutagenesis. 
An important improvement on the standard oligonucleo-
tide-directed mutagenic strategies has been termed site-
saturation or cassette mutagenesis (13-15). This technique 
allows the simultaneous generation of at least twenty muta-
tions at a single amino acid residue, thus eliminating the 
need for predicting which mutations may be of interest. By 
standard mutagenic techniques restriction endonuclease sites 
are created that flank the codon to be mutated and that are 
separated by a short distance (one that can be spanned by 
synthetic oligonucleotides). The intervening sequence is 
excised by endonuclease digestion and replaced by ligation 
with a linear duplex sequence made by annealing complementary 
synthetic oligonucleotides that contain a mixture of codons 
in place of the wild-type codon. The mixture of mutated 
plasmids is used to transform ~ coli and the resulting 
mutations characterized either by a phenotypic screen or by 
sequencing individual colonies. 
A variety of systems have been studied using oligonuc-
leotide-directed mutagenesis, and a wide range of questions 
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have been addressed. The following discussion attempts to 
provide examples of some approaches using oligonucleotide-
directed mutagenesis to answer questions about the structural 
requirements for protein function. Specific problems that 
have been addressed include determination of the roles of 
specific amino acids in catalysis and in substrate binding, 
in allosterism, in protein stablility, in protein-protein 
interactions, and in protein-DNA interactions. In general, 
target residues for mutagenic experiments are decided on the 
basis of existing structural or kinetic information. Data 
from x-ray structures, chemical modification experiments, or 
from sequence comparisons may indicate sites that are of 
interest. 
The role of an individual amino acid in catalysis has 
been assessed using oligonucleotide-directed mutagenesis on 
triosephosphate isomerase {TIM). TIM interconverts dihydro-
xyacetone phosphate {DHAP) and glyceraldehyde 3-phosphate 
{GAP) . Glul65 was postulated on the basis of chemical mod-
ification experiments (16) and the crystal structure (17) to 
participate in catalysis as a general base, first accepting 
the pro-R hydrogen of DHAP and then protonating the resulting 
enediol at C-2 to form DGAP. The mutant Glul65-->Asp was 
constructed and found to have kcat for the forward reaction 
reduced by a factor of 240 while KM for the forward reaction 
was increased by a factor of 2, confirming that Glul65 is 
important for catalysis but involved only slightly in the 
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binding of substrate (18). A more detailed study of the 
kinetics of catalysis by the Glul65-->Asp mutant has been 
carried out by measuring the isotope effect on incorporation 
of solvent protons into the product. An increase relative to 
the wild-type enzyme of 4 kcal/mole in the energies of the 
transition states between the enediol intermediate and enzyme 
bound substrate and product was calculated (19). 
The energetics of substrate-active site interactions 
and how they affect catalytic efficiency have been investi-
gated using a series of mutations of tyrosyl tRNA synthetase 
(TStyr, reviewed in ref. 22). TStyr from JL.. stearothermo-
philus is a dimer of 47.5 kdalton subunits whose crystal 
structure has been solved to 3.0 A resolution with (20) and 
without (21) substrate bound to the active site. The enzyme 
catalyzes the transfer of tyrosine to tyrosyl tRNA, after 
forming a tyrosyl-AMP intermediate. Examination of the crys-
tal structure implicated several residues as being involved 
in hydrogen bonds to the intermediate, tyrosyl adenylate. 
Thr40 and His45 are involved in hydrogen bonds to the ~­
phosphate of the tyr-ATP transistion state. The energetics 
of this interaction were determined by creating mutations 
which removed the hydrogen bonds causing an increase in the 
energy of the transition state but no significant change in 
the binding of substrates. cys35 was observed to contri-
bute a good hydrogen bond to the C(3) hydroxyl of the ribose 
ring of ATP. Mutants Cys35-->Ser and Cys35-->Gly were con-
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structed and shown to have reduced affinities for substrate 
ATP because of the complete removal of the hydrogen bond 
(Cys35-->Gly) or its slight displacement (Cys35-->Ser) (23). 
The Cys35-->Ser mutant had a lower affinity for ATP than the 
Cys35-->Gly, a difference that was attributed to the ability 
of Cys35-->Ser to hydrogen bond to water in the absence of 
substrate. Energy would be required to break the hydrogen 
bond to water, decreasing the energy available for binding 
substrate. A similar effect was reported for mutations at 
Thr51 which was observed in the crystal structure to be in-
volved in a weak hydrogen bond to the ribose ring oxygen (0-
1) . The Thr51-->Ala mutant showed a slightly raised affinity 
for ATP (24). Interestingly, a Thr51-->Pro mutant showed a 
25-fold increase for the rate of the first reaction catalyzed 
(the formation of tyrosyl adenylate) by TStyr due mainly to a 
lower KM for ATP (24), and explained by local distortions in 
the peptide backbone, which influenced the position of His48 
so that it had an improved hydrogen bond to 0-1 (25). 
Oligonucleotide-directed mutagenesis has also been used 
to study serine proteases. The binding of substrate to 
trypsin from rat pancreas has been investigated. Trypsin 
catalyzes the cleavage of peptide bonds with a specificity 
for peptides containing lysine or arginine. Mutations 
converting Gly216 and Gly226, both located in the substrate 
binding site, to alanine, separately and as a double mutation 
affected the specificity (kcatfKM) of the enzyme for arginyl 
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and lysine-containing substrates (26). The wild-type enzyme 
shows a specificity for arginyl substrates. The Gly216-->Ala 
mutant shows an enhanced specificity for arginyl substrates, 
but the Gly226-->Ala mutant has a higher specificity for 
lysine-containing substrates. The double mutant, Gly216--> 
Ala/Gly226-->Ala, had a lowered specificity for arginyl 
substrates. 
For subtilisin, the variation in activity with pH was 
altered by introducing a mutation converting Asp99 to serine. 
The mutant showed a reduced catalytic efficiency at alkaline 
pH, despite the location of the mutation 14-15 A from the 
active site. The authors concluded that the results were due 
to long range electrostatic effects (27). 
The roles of active site residues in the catalytic 
mechanism of dihydrofolate reductase (DHFR) have been inves-
tigated. DHFR catalyzes the NADPH-dependent reduction of 
7,8-dihydrofolate to 5,6,7,8-tetrahydrofolate. The car-
boxyl group of Asp27 is believed to stabilize a protonated 
transition state. An Asp27-->Asn mutant was constructed and 
found to have only 0.1% of the activity of wild-type enzyme 
(28). Structural requirements for catalysis were also 
studied by removal of a cis peptide bond between Glyl95 and 
Glyl96, by creating a Gly195-->Ala mutant, which resulted in 
the total loss of activity. A Pro39-->Cys mutant was able to 
form a disulfide bond with Cys85 wich caused a reduction in 
activity (28). The role of Leu54 was investigated by ere-
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ating a mutant converting it to glycine. The mutant had an 
increased rate of substrate release and a decrease of 104 in 
the rate of hydride transfer indicating a change in the rate-
determining step from product release for the wild-type to 
hydride transfer for the mutant, despite the location of 
Leu54 10 A from the active site (29). 
One of the most striking examples of the effects of 
point mutations on biological activity is the activation of 
proto-oncogenes. The cellular analog of the transforming 
gene of Harvey murine sarcoma virus (c-Ha-ras) is able to 
transform cells when mutations in codon 12, normally coding 
for glycine, are present (30). All 19 mutations at residue 
12 were constructed by oligonucleotide-directed mutagenesis 
and tested for their ability to transform NIH 3T3 cells. All 
but Glyl2 and Glyl2-->Pro were able to transform cells. The 
authors suggested that these two mutants affect an oc-helical 
structure in that region of the protein necessary for the 
protein's ability to cause transformation (31). 
Investigations of the importance of phosphorylation of 
tyrosines on the transforming properties of oncogene products 
have utilized oligonucleotide-directed mutagenesis. The 
middle-T antigen of polyoma virus can transform cultured rat 
cells (32). Middle-T antigen maintains a tyrosine-kinase 
activity probably due to its association with pp6oc-src, a 
cellular proto-oncogene product (33). The association causes 
an increase in the specific activity of the kinase (34). 
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Middle-T antigen is itself a substrate for the kinase activ-
ity, and the effect of phosphorylation of several tyrosines 
on its transforming ability has been determined by the use of 
site-directed mutagenesis to convert known tyrosine phosphate 
acceptors to phenylalanine. Tyrosines 315, 250, 372, and 297 
are known to be phosphate acceptor sites. Deletion of Tyr322 
or Tyr297 had no apparent effect on transforming activity 
(35). A mutation converting Tyr250 to Phe caused a reduction 
in transforming ability (36) as judged by a focus formation 
assay. Mutations converting Tyr315, the major site of 
phosphorylation, to phe have produced conflicting results, 
either causing a drastic reduction (36) or little change 
(35,37) in transforming ability. Differences in the assays 
and cell lines used probably account for the different 
results. Similar experiments on the oncogene of Rous sarcoma 
virus, pp6ov-src, have shown that phosphorylation of Tyr416 
is not essential for transformation since the mutant Tyr416-> 
Phe could cause transformation (38). An autophosphorylation 
site, Tyrl073, of Pl30gag-fps, the oncogene product of 
Fujinami sarcoma virus, was mutated to serine and threonine. 
Neither ser nor thr were autophosphorylated and the mutants 
had lowered enzymatic and oncogenic activities (39) . The 
ability of the c-ras-encoded protein, p21, the cellular 
analog of the transforming gene of Harvey murine sarcoma 
virus, to bind GTP was abolished by conversion of Asnll6 to 
either lysine or tyrosine. The mutants also lost their 
11 
ability to autophosphorylate and to transform NIH3T3 cells 
( 40) • 
Oligonucleotide-directed mutagenesis has proven useful 
in the study of the roles of individual amino acids in the 
allosteric regulation of activity. Mutants of aspartate 
transcarbamoylase (ATCase) have been constructed. ATCase 
catalyzes the conversion of carbamoyl phosphate and aspartate 
to carbamoylaspartate and inorganic phosphate, the first 
committed step in pyrimidine biosynthesis. The enzyme 
consists of six 34 kdalton catalytic subunits and six 17 
kdalton regulatory ·subunits. Homotropic cooperativity is 
exhibited by both substrates and feedback inhibition is 
accomplished by the heterotropic inhibitor, CTP. ATP acts as 
an heterotropic activator to ensure the equal production of 
purines and pyrimidines. Biophysical techniques and x-ray 
structures on the enzyme alone and in the presence and N-
phosphonoacetyl aspartate (41) (PALA, a competitive inhibitor) 
indicate a substantial restructuring of the holoenzyme on 
binding of the allosteric effectors. The roles of several 
individual amino acids in mediating the conformational 
changes of the enzyme have been investigated. Target res-
idues were identified by examining data from chemical mod-
ification studies in addition to the xray data. A mutant 
converting Glnl33, known to reside near the contact region 
between the catalytic and regulatory subunits, to Ala caused 
a marked increase in cooperativity without effecting activity 
12 
(42). From the x-ray crystal structure, Hisl34 was shown to 
be in proximity to the phosphate binding site and was sug-
gested as a possible proton donor to the transition state. 
Mutation of Hisl34 to Ala resulted in a mutant with 5% of the 
catalytic activity of the wild-type, considerable coopera-
tivity and increased substrate binding constants (42). Mu-
tation of Tyrl65, which was thought to be in the substrate 
binding site from chemical modification studies, caused an 
increase in binding constants for both aspartate and car-
bamoyl phosphate, and Vmax decreased to about 30% of the 
wild-type value. Cooperativity was also decreased (43). 
Lys84 was suggested on the basis of inactivation by pyridoxyl 
phosphate and NaBH4 to be essential for catalysis (44). Sub-
stitution of Arg or Gln for Lys 84 gave a mutant possessing 
only 0.05 or 0.01 % of the activity of the wild-type enzyme, 
respectively. Chemical modification of Lys83 caused con-
siderable inactivation. However, substitution of Gln for 
Lys83 caused little change in activity (42). A loop of the 
protein containing residues 230-245 was shown to undergo a 
large movement on changing from the T to the R state. Tyr240 
was converted to Phe in a mutant that showed altered homo-
tropic interactions and a different reactivity towards p-
hydroxymercuribenzoate in the unligated state suggesting an 
altered conformation (45). 
The contribution of disulfide bonds to the thermal 
stability and conformation of proteins has been studied. 
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successful attempts to engineer disulf ides into proteins to 
increase the thermal stability have taken into consideration 
not only the proximity of the two sites for placing cysteines 
but also their relative orientations in the three-dimensional 
structure of the protein since not all dihedral angles are 
conducive to disulfide formation. An intramolecular disulfide 
bond was "engineered" into T4 lysozyme by replacing Ile3 with 
Cys which could then form a bond with Cys97 (46). The disul-
fide-containing mutant had a substantially increased thermal 
stability. An intermolecular thiol-disulfide exchange re-
action was shown to occur with unpaired Cys54, leading to 
production of inactive oligomers of the Ile3-->Cys mutant. 
This reaction was prevented by converting cys54 to Thr or Val 
(47). Human interleukin-2 contains a disulfide bridge be-
tween Cys58 and Cysl05 and a free Cys at position 128. Mu-
tant cys58-->Ala showed 250 times less activity than wild-
type while mutant cysl05-->Ala showed 8-10 times less activ-
ity. Cysl28-->Ser showed comparable activity to wild-type 
(48). The lac permease of~ coli catalyzes the H+;a gal-
actoside symport. A secondary structural model of the single 
polypeptide chain of the protein based on hydropathic anal-
ysis and circular dichroic measurements proposes that 12 a-
helical domains span the membrane. A mutation converting 
Gln60, which resides in the middle of the second proposed ~­
helix from the N-terminus, to Glu caused a decrease in the 
thermal stability. The mutant lost activity at 45•c with a 
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half-life of 20 minutes while the wild-type had a half-life 
of 50 minutes (49). Removal of the disulfide bond of RTEM-1 
B-lactamase, the enzyme responsible for bacterial resistance 
to penicillins, by conversion of Cys77 to serine caused a 
decrease in the thermal stability and stability at alkaline 
pH of the enzyme though the catalytic parameters at lower 
temperatures and neutral pH had not measurably changed (50). 
General methods for increasing the thermal stablility of 
proteins have been proposed (51). Comparison of the primary 
sequences of the neutral protease of thermophilic and 
mesophilic bacteria suggested the construction of a mutation 
containing the substitution Glyl44-->Ala, which is of higher 
thermal stability than the wild-type enzyme (52). Individual 
mutants of kanamycin nucleotidyl transferase that enhance the 
thermostability of the enzyme have been identified (53). The 
combination of two separate mutations into a double mutant 
resulted in a cumulative enhancement of stability (54). The 
stability of subtilisin to oxidative inactivation has been 
improved by mutagenesis (55). Mutation of Met222, the site 
of oxidation, to nonoxidizable amino acids, such as Ser, Ala, 
or Leu, prevented inactivation by peroxide. A mutant ofa1-
antitrypsin, a protease inhibitor, which converted Met358 to 
valine was more resistant to oxidative inactivation by N-
chlorosuccimide than the wild-type enzyme (56). 
Alterations in the interactions at the interface of 
protein dimers have been made. Phel64 of tyrosyl tRNA syn-
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thetase interacts with its partner Phel64 in the active 
dimer. A mutant converting Phel64 to Asp showed a shift in 
the pH dependence of activity. At pH 6, where dimerization 
is favored, the mutant was fully active. At pH 7.8, dis-
sociation of the dimer was favored and the activity was low-
ered (57). Mutagenesis of ACI repressor converted Tyr88, 
known to interact with its partner Tyr88 in the dimer, to cys 
created a mutant which could then spontaneously form a disul-
fide bridge in the dimer without perturbing the structure of 
the dimer. The mutant was shown to have an increased binding 
affinity for its operator sequence. In contrast, a mutant 
converting Tyr85, which was known to be distant from its 
partner Tyr85 in the dimer, to Cys created a mutant which 
could not spontaneously form a disulfide bond. Reaction with 
dithio-2-nitro benzoic acid caused dimer formation and the 
dimers had a 10-fold reduced affinity for the operator 
sequence (58). 
The mechanisms of recognition and binding interactions 
between sequence specific DNA-binding proteins and their DNA 
substrates have been explored using oligonucleotide-directed 
mutagenesis. A synthetic gene for the A cro protein was con-
structed by ligation of a series of oligonucletoides, in-
cluding conveniently located sites for restriction endonuc-
leases (59). Excision of segments of the wild-type sequence 
and replacement with a duplex strand of oligonucleotides 
allowed the rapid production of several single amino acid 
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replacements. Several mutations in the ~-3 helix, one of the 
helices thought to determine DNA sequence specificity, al-
tered the affinity of cro for its operator sequence. Tyr26 
was suggested on the basis of the xray structure to donate a 
hydrogen bond to 04 of a thymine (60). Conversion of Tyr26 
to Asp caused a substantial reduction in affinity for the OR3 
operator sequence, while conversion of Tyr26 to Phe caused an 
intermediate level of affinity. Interestingly, converting 
Tyr26 to lysine had little effect on the binding affinity, 
results explained by an ionic interaction between the lysine 
and the phosphate backbone substituting for the lost hydrogen 
bond . Gln27 was thought to be involved in two hydrogen bonds 
as both a donor and acceptor with an adenine. Substitution 
of Leu, Cys , or Arg for Gln27 resulted in a large decrease 
in binding affinity. Serine 28 was thought to be involved in 
two hydrogen bonds to an adenine. Removal of the hydroxyl of 
serine by conversion to alanine caused a pronounced decrease 
in binding affinity (60). The DNA-binding specificity of 
bacteriophage 434 repressor was changed to the specificity of 
the repressor from bacteriophage P22 by altering five amino 
acids on one side of an ~ helix, the side thought to form 
specific contacts with the operator sequence (61). 
Although the use of oligonucleotide-directed mutagenesis 
is still in its infancy, it has proven helpful in resolving 
questions about the relationship between structure and func-
tion in proteins. Applications of the method to other sys-
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tems and further refinement of the technique should amplify 
its usefulness. 
The work of this thesis involves the use of oligonuc-
leotide-directed mutagenesis to study the roles of highly 
conserved amino acids in the active site of RTEM-1 B-lacta-
mase [EC(3.5.2.6)], the enzyme encoded by the bla gene of 
plasmid pBR322. The conserved Thr at position 71 was re-
placed with cysteine as described in Chapter 2. The "satur-
ation" of Lys73 with all possible single site mutations is 
described in Chapter 3, and the kinetic characterization of 
two mutants at position 73, Lys73-->Arg and Lys73-->Cys is 
documented in Chapter 4. 
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Construction and Kinetic Characterization 
of a Thr71-->Cys Mutant of RTEM-1 B-lactamase 
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Introduction 
B-lactamases catalyze the hydrolysis of the B-lactam 
ring of penam and cephem antibiotics (1). They are princi-
pally responsible for resistance to these antibiotics in pro-
karyotes and therefore have been subjects of interest to 
biochemists and medical researchers alike. B-lactamases from 
different bacterial sources have been classified into three 
groups, A, B, and c, on the basis of structural and catalytic 
similarities (2). Class A B-lactamases have molecular 
weights of approximately 28,000 daltons, catalyze the hydrol-
ysis of penams at higher efficiency than cephems, and in-
clude the ~ aureus PCl, ~ licheniformis 749/c, ~ cereus 
569/Hl, and the RTEM enzymes. Class B consists of the metal-
lo-enzymes from ~ cereus and ~ maltophilia (3). Class c 
enzymes have molecular weights of approximately 38,000 dal-
tons, hydrolyze cephems at higher efficiency than penams and 
include the enzymes from~ aeruginosa and~ coli Kl2 (4). 
Class c enzymes also show the ability to transfer the hy-
drolyzed B-lactam antibiotic to an exogenous nucleophile such 
as methanol and catalyze the hydrolysis of the resultant 
ester (5). 
The B-lactamase used in this work is the RTEM-1 enzyme 
encoded by pBR322. The RTEM enzymes are named after the 
strain of ~ coli from which they were first isolated. The 
RTEM-1 enzyme has an isoelectric point of 5.4 and the RTEM-2 
enzyme, encoded by plasmid RPl, has an isoelectric point of 
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5.6, which reflects a single amino acid difference. The 
RTEM-1 enzyme has glutamine at position 39, where the RTEM-2 
enzyme has a lysine. The RTEM-1 enzyme is synthesized as a 
preprotein and secreted from the cytosol to the periplasm 
with the proteolytic loss of a 23 amino acid leader sequence. 
The mature form of the enzyme has a molecular weight of 28.5 
kdaltons. 
Class A B-lactamases maintain a conserved triad of amino 
acids, Ser-Thr-Xaa-Lys (2). The serine of the conserved 
triad has been implicated as the active site nucleophile by 
studies of its interaction with an irreversible inactivator 
6-Bbromopenicillinanic acid (6,7,8). The role of the con-
served Thr has been investigated by cassette mutagenesis (9) 
to replace the Thr71 of RTEM-1 B-lactamase with the other 
nineteen amino acids. Cells harboring all mutants except 
Thr71-->Lys, Arg, Tyr, Trp, and Asp showed a resistant phe-
notype to B-lactam antibiotics and all were apparently less 
thermally stable than the wild-type enzyme. The physical and 
catalytic properties of the mutants Thr71-->Ser and Ile have 
been studied in some detail (10,11). These results have 
supported the general conclusion that Thr is conserved at 
position 71 of RTEM-1 B-lactamase more for purposes of pro-
tein stability and less for binding of substrate or for ca-
talysis. 
This chapter describes the construction and kinetic 
characterization of the mutant Thr71-->Cys of RTEM-1 B-lac-
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tamase. The mutant was constructed by cassette mutagenesis 
using the three fragment ligation scheme (9) to ligate a 
duplex strand of synthetic oligonucleotides containing the 
desired double mutation ACT-->TGT, replacing the Thr71 codon 
with that of Cys into a modified form of pBR322. Cells har-
boring the mutant have a resistant phenotype to B-lactam an-
tibiotics. Purified mutant enzyme is active against benzyl-
penicillin, cephalothin, and 6-aminopenicillanic acid (6-
APA), although at lower efficiency than the wild-type enzyme. 
The mutant has an altered pH-activity profile, showing in-
creased sensitivity to activity loss at alkaline pH. The 
mutant is sensitive to inactivation by parachloromercuriben-
zoate (pCMB) under conditions where activity of the wild-type 
is not affected. The mutant is less stable to thermal dena-
turation than the wild-type enzyme as are all other mutants 
at position 71 (10,11). 
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Materials and Methods 
Enzymes and Chemicals 
Restriction enzymes and the large (Klenow) fragment of 
DNA polymerase I were purchased from Boehringer Mannheim. T4 
polynucleotide kinase and T4 DNA ligase were from Bethesda 
Research Laboratories. Antibiotics were obtained from Sigma 
Chemical Co. (St. Louis, Mo.) The (~-32P]dTTP, 3000 µCi/mmol 
was obtained from Amersham, and the (~-32P]ATP was from ICN 
(Irvine, CA). Tryptone and yeast extract were from Difeo 
(Detroit, MI). All other chemicals used were reagent grade. 
Bacterial strains 
E. Coli strain LSl (12) was used as host of plasmid 
pBR322 and the derivatives of pBR322. E. Coli strain Dl210 
was used as the host strain for plasmid pJN and is a lac Iq 
derivative of HBlOl. 
DNA 
Oligonucleotides were synthesized by using the phos-
phoramidite chemistry (13) on the Applied Biosystems (Foster 
City, CA) DNA synthesizer, model 380A and purified by prep-
arative polyacrylamide gel electrophoresis, followed by 
desalting by G-25 chromatography. 
DNA fragments were purified by electrophoresis on 1.2% 
agarose gels and electroeluted using either DEAE-cellulose 
paper or an International Biotechnologies, Inc. (New Haven, 
CT) UEA electroeluter. 
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Plasmid DNA was prepared by the alkaline lysis method 
(14). The numbering system for pBR322 is the one commonly 
used (15). 
Reactions and Mutagenesis 
The complementary mutagenic oligonucleotides were 
phosphorylated using standard procedures (15), and were 
annealed by mixing 0.4 pmole/µL of each strand and heating to 
95°C in 10 mM MgC1 2 , 50 mM Tris-HCL, pH 8, followed by slow 
cooling to room temperature over a one hour period. 
The three fragment ligation scheme was used (9). A 
sample of plasmid pBR322ss (a derivative of plasmid pBR322 
containing an additional Ava! restriction site at 3972 bp 
and an additional Sea! restriction site at 3937 bp, and 
missing the Sea! restriction site at 3846 bp) was digested 
with 7 units each of Sal! and Sea! restriction endonuclease 
and the resulting 3286 bp fragment was isolated from a 1.2% 
agarose gel as described above. Another sample of pBR322ss 
was digested with 7 each units of Ava! and Sal! restiction 
endonucleases and the resulting 1042 bp fragment was 
isolated. The following mutagenic sequence, 
5 1 CC GAG GAA CGT TTT CCA ATG ATG AGC (TGT) TTT AAA GT 3 1 
C CTT GCA AAA GGT TAC TAC TCG (ACA) AAA TTT CA 5', 
was kinased and annealed as described. For the ligation, 
approximately 0.04 pmole of each restriction fragment and 
0.4 pmole of the synthetic fragment were added in 10 mM 
MgCl2, 50 mM Tris-HCl, pH 8, 0.5 mM ATP, 5 mM dithiothreitol 
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with 10 units of T4 DNA ligase and incubated at 15°C for 
approximately 16 hours. The ligation was terminated by 
heating to 65°C for 10 minutes and a 10 µl aiiquot of the 
ligation mixture was used to transform ~ coli LSl to 
tetracycline resistance, using standard transformation 
procedures (16). 
Screening 
To ensure the presence of the desired mutation, plasmid 
DNA derived from an individual colony was digested with EcoRI 
restiction endonuclease in medium buffer (15) and then 
electrophoresed on a 1.2% agarose gel. A control sample of 
plasmid pBR322 was also digested with EcoRI and electrophor-
esed in an adjacent lane. DNA was transferred to nitrocel-
lulose (Schleicher and Schuell, BA 85) by standard techniques 
(15), and fixed by heating to 80°C in vacuo for 90 minutes. 
The following mutagenic oligonucleotide was kinased with [i-
32P]ATP and used for screening. 
5 1 TG ATG AGC TGT TTT AAA G 3 1 
The nitrocellulose was washed with prehybridization buffer 
(0.2% sos, lOx Denhardt's solution (3), 0.1 mg/ml sonicated 
denatured salmon sperm DNA, 1 mM sodium orthophosphate, 1 mM 
sodium pyrophosphate, 0.5 mM ATP, and 6x SSC buffer (15)) for 
30 minutes. The filter was then hybridized at room temper-
ature in a solution containing 0.2% sos, lOxDenhardt's 
solution, 0.25 mg/ml yeast tRNA (Sigma, phenol extracted), 1 
mM sodium orthophosphate, 1 mM sodium pyrophosphate, 0.5 mM 
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ATP, 6xSSC buffer, and 1 to 2 ng/ml of the labeled oligo-
nucleotide. 
The filters were washed in 6xSSC buffer three times for 
three minutes each wash, first at room temperature and then 
at 5 degrees below the estimated melting temperature, Td, as 
determined by the following equation, Td = 4(# GC bps) + 2(# 
AT bps) . Autoradiograms were taken after each wash. 
Sequencing 
To confirm the presence of the desired mutation, plasmid 
DNA was sequenced by the following procedure. Plasmid was 
digested with-Ava! restriction endonuclease and the resulting 
2962 bp fragment isolated as described before. The fragment 
was labeled at nucleotide T-3973 using [~-32p] dTTP and the 
large (Klenow) fragment of DNA polymerase I, as shown in 
Figure 2. The labeled fragment was precipitated from the 
polymerase solution with 2.5 volumes of ethanol and pelleted 
by centrifugation. The pellet was washed with 70% ethanol 
and dried in a Speedvac. The labeled fragment was sequenced 
by the method of Maxam and Gilbert (17). The sequencing gels 
were 40 cm long and contained 20% polyacrylamide (wt/vol) and 
40% urea and were run using standard conditions (15). 
Subcloning into pJN 
Plasmid pBR322T71C and plasmid pJN were digested with 
EcoRI and PvuI restriction endonucleases and the resulting 
626 bp and 4800 bp fragments isolated by electroelution, 
respectively. The 626 bp EcoRI-PvuI fragment of plasmid 
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pBR322T71C was ligated to the 4800 bp PvuI-EcoRI fragment of 
plasmid pJN using procedures described above. Transformation 
of E. Coli 01210 to kanamycin resistance was performed as 
described. To confirm the presence of the mutated gene, 
plasmid derived from a kanamycin resistant colony was di-
gested with Ava! restriction endonuclease and run on a 1.2% 
agarose gel. The additional Ava! restriction site from 
pBR322ss was confirmed. 
Purification of Thr71-->Cys 
The purification procedure used was a slight variation 
of the published procedure (10). 
A frozen stock of ~ coli strain 01210 harboring 
plasmid pJNT71C was used to inoculate 300 ml of L broth (10 
g tryptone, 5 g yeast extract, 10 g NaCl per liter) contain-
ing 25 mg/L kanamycin. The culture was grown at 37°C with 
shaking for 7 to 9 hrs. Fifty mls of the culture was used to 
inoculate 10 L of FB media (25 g tryptone, 7.5 g yeast 
extract, 50 ml of 1 M Tris, pH 7.5, 30 g NaCl per L) con-
taining 25 mg/L kanamycin. The culture was grown in a New 
Brunswick Scientific Co. fermenter at 30°C with vigorous 
aeration for 12 to 14 hours. The temperature was dropped to 
30°C and IPTG was added to 0.1 mM. The induction was al-
lowed to continue for 2 to 3 hours with aeration and then 
the cells were collected by centrifugation. The osmotic 
extrusion was performed as described (18). Solid ammonium 
sulfate was added to the extrudate to reach 20% (w/v). The 
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solution was stirred at 4°C for several hours. Occasionally 
a precipitate appeared and was removed by centrifugation at 
10 Krpm in a GSA rotor for 30 minutes. Solid ammonium 
sulfate was added to the supernatant to reach 60% (w/v), and 
the solution stirred at room temperature for 12-16 hours. 
The precipitate was collected by centrifugation at 10 Krpm 
for 45 minutes and dissolved in 200 mls distilled deionized 
water and dialyzed against water containing 0.02% sodium 
azide using a Diaflo fitted with a PM-10 membrane. After 
removal of ammonium sulfate, the solution was changed to 25 
mM triethanolamine, · pH 7.25 and applied in 30-50 mls to a 
2.5 x 25 cm DE-52 column. Protein was eluted using a linear 
gradient from 25 to 200 mM triethanolamine, pH 7.25. Frac-
tions corresponding to the activity peak were pooled and 
dialyzed into 20 mM Tris, pH 6.75, and applied to a 1 x 82 
cm Ultragel ACA 54 column in several 0.5 ml portions. 
Yields using this procedure were generally poor, about 1 to 
2 mgs of protein probably due to the thermal instability of 
the mutant. 
Assays 
Protein concentrations were determined by absorbance at 
281 nm using the conversion factor, 29,400 M-lcm-1 (19). Ac-
tivity assays were done at 30°C (unless otherwise indicated) 
in 0.1 M potassium phosphate, pH 7, using either a Beckman 
Acta CIII or DU-7 spectrophotometer with 1 cm pathlength 
cells for assays of activity on benzylpenicillin and 6-amino-
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aminopenicillanic acid. For assays of activity on cephalo-
thin an optical quartz block was inserted into the cuvet to 
reduce the pathlength to 1 mm. Hydrolytic cleavage of ceph-
alothin was followed at 265 nm, and at 240 nm for benzyl-
penicillin and 6-aminopenicillanic acid (19). The ~(values 
for cephalothin, benzylpenicillin, and 6-aminopenicillanic 
acid were 7900, 500, and 500 M-lcm-1 respectively (19). 
Inactivation by pCMB 
To 125 µL mutant and wild-type B-lactamase in 20 mM 
Tris, pH 6.75 and 7, respectively was added 2.5 µL of a 5 mM 
parachloromercuribenzoic acid in 0.01 M sodium carbonate. 
Aliquots were removed at timed intervals and assayed for 
residual activity. To determine the effect of substrate on 
the inactivation a control sample of the mutant B-lactamase 
was made 1 mM in benzylpenicillin and treated as described 
above. 
Activity vs pH 
The pH of the assay buff er was varied from pH 5 to pH 
8.4. Aliquots of mutant and wild-type B-lactamase were added 
and assayed immediately. 
Thermal stability 
Mutant B-lactamase was incubated at the indicated tem-
peratures in 80 mM sodium phosphate, pH 7. At timed inter-
vals aliquots were removed and assayed for residual activity 
on benzylpenicillin at 30°C. 
Inhibition by borate 
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Assay buffer was made from O to 10 mM borate. Reaction 
progress curves at low substrate concentrations, those 
approaching the KM of benzylpenicillin, were determined using 
a constant amount of mutant B-lactamase. 
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Results 
The three fragment ligation scheme used to create the 
mutant, Thr71-->Cys, is outlined in Figure 1. Plasmid 
pBR322SS is a derivative of pBR322 containing an additional 
restriction site for AvaI at 3972 bp from the EcoRI site and 
an additional site for Scar at 3936 bp, sites that flank the 
active site serine-70 codon of the B-lactamase gene. The 
ScaI site of pBR322 at 3846 bp was removed (9). Ligation of 
the annealed, kinased oligonucleotides to the two plasmid 
fragments followed by transformation by the method of Hanahan 
(16) gave approximately 200 tetracycline-resistant colonies. 
seven of the eight TetR colonies that were plated onto L agar 
plates containing 200 mg/ 1 ampicillin showed a resistant 
phenotype. Plasmid prepared from one of the TetR, AmpR 
colonies was screened for the presence of the desired muta-
tion using a 32P-labeled hybridization probe containing the 
TGT codon for position 70. Thus, the probe has a double 
mismatch on binding to the wild-type sequence leading to a 
large decrease in the melting temperature compared to the 
probe bound to the mutated sequence, a difference distin-
guishable even at room temperature as shown in Figure 2. To 
confirm further the existence of the mutation plasmid 
pBR322T71C was sequenced by the Maxam-Gilbert technique (17). 
The sequencing strategy outlined in Figure 3 takes advantage 
of the assymmetric overhangs left on digestion by AvaI res-
triction endonuclease. Labeling at the end closest to the 
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active site is accomplished by the addition of [~-32]dTTP to 
that end by the Klenow enzyme. 
Purification of the mutant protein was accomplished 
using plasmid pJN, which contains the tac promoter (20, 21) 
and the gene for kanamycin resistance. The mutant Thr71--> 
cys gene was ligated into pJN as an EcoRI-PvuI fragment and 
its placement was confirmed by the presence of the addition-
al Aval restiction site at 3969 bp. The host strain for pJN 
was ~ coli strain 01210 which expresses the lac repressor 
constitutively, shutting off expression of B-lactamase until 
the addition of IPTG. Induction was carried out at 3o0 c to 
minimize activity loss due to the known thermal instability 
of the Thr71-->Cys mutant. Despite this precaution yields 
were generally low, about 1 to 2 mgs for a 10 L growth. This 
quantity of enzyme is sufficient for kinetic studies. The 
final buffer pH was kept below 7 due to the discovered in-
stability of the mutant at alkaline pH. The DE-52 column 
profile is shown in Figure 4. The protein used in the ki-
netic studies was determined to be homogenous by 12% sos-
PAGE (22). 
The Michaelis-Menten parameters were determined for the 
substrates benzylpenicillin, cephalothin, and 6-aminopeni-
cillanic acid and are shown in Table 1. The values for kcat 
and KM were determined from Lineweaver-Burk (23) plots 
generated by following reaction progress curves and using 
[SJ, the average substrate concentration, and v, the average 
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reaction rate for a region of the reaction progress curve 
according to published procedures (24). The value of 
kcat/KM, a measure of the efficiency of enzymatic catalysis, 
of the mutant is 12% for benzylpenicillin, 3% for cephalothin 
and 9% for 6-aminopenicillanic acid of the value of kcat/KM 
for the wild-type enzyme. 
The activity of the Thr71-->Cys mutant was determined at 
various pH values ranging from 5.5 to 8.4 and the results are 
shown in Figure 6. The mutant shows an increased sensitivity 
to activity loss at alkaline pH compared to the wild-type 
enzyme. This activity loss is completely reversible on the 
assay time scale (20 minutes) up to a pH of approximately 
8.2. At pH greater than 8.2 the assay was not linear but 
decreased gradually suggesting the denaturation of the mu-
tant. By contrast the activity of the wild-type enzyme was 
linear up to the highest pH tested, pH 8.4. The Michaelis-
Menten parameters for the Thr71-->Cys mutant were determined 
at pH 8.1 for PenG and are shown in Table 2. 
The Thr71-->Cys mutant was shown to be sensitive to 
inactivation by pCMB at a concentration (100 ~M) that does 
not affect the activity of the wild-type enzyme, as shown in 
Figure 7. As a control reaction to show that the inactiva-
tion is due to specific reaction at the active site, benzyl-
penicillin was added to the inactivation reaction. The pres-
ence of 1 mM benzylpenicillin in the inactivation reaction 
decreased the initial rate of activity loss and the inactiv-
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ation ceased at about 60% of the original activity. This 
"protection" against inactivation is most probably due to 
formation of an adduct between the benzylpenicillin and the 
pCMB, possibly between the thiazolidine ring sulfur and the 
mercury of the pCMB. Under the conditions employed for the 
inactivation the substrate is in a 10:1 excess over the pCMB 
and would halt inactivation by reacting with all of it. How-
ever, the wild-type enzyme serves as a sufficient control 
demonstrating inactivation occurs by reaction at Cys71 since 
it differs from the mutant at this position only. 
The thermal stability of the Thr71-->Cys mutant is 
reduced relative to that of the wild-type enzyme as show in 
Table 3 and in Figure 7. The mutant shows a significant and 
rapid loss of activity above 40"C while the wild-type enzyme 
is relatively stable until the temperature reaches 50-55°C. 
Borate ion competitively inhibits both the wild-type and 
Thr71-->Cys mutant. The Kr of borate is 1 mM for the wild-
type enzyme (25). The Kr for borate and the Thr71-->Cys was 
determined to be 2.5 mM by measuring reaction progress curves 
for the hydrolysis of benzylpenicillin in the presence of 
from 2 to 10 mM borate ion, using substrate concentrations 
ranging from 1 to 3 times the KM value. 
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Discussion 
Cassette mutagenesis provides a rapid and efficient 
method for the production of structural mutants of a protein, 
when restriction sites flanking the codon of interest are 
present. Cassette mutagenesis has distinct advantages over 
oligonucleotide mutagenesis; more than one mutant may be 
generated at the same time at nearly equal frequencies, a 
large number of base changes can be incorporated g~nerating 
changes in more than one codon simultaneously, and the tedi-
ous screening procedures of oligonucleotide-directed muta-
genesis are eliminated. Cassette mutagenesis has been used 
to produce the mutation Thr71-->Cys in RTEM-1 B-lactamase, 
placing a cysteine adjacent to the active site serine. 
The replacement of Thr71 with cysteine was carried out 
in order to complete the permutations of Cys, Ser, and Thr at 
positions 70 and 71 of B-lactamase. The mutants Cys70--> 
Thr71, Ser70-->Ser71, Thr70-->Ser71, have already been con-
structed and their physical and catalytic properties examined 
(26, 10). Since Thr70-Ser71 shows no catalytic activity, the 
construction of Thr70-Cys71 was deemed unnecessary. The 
mutant Cys70-Cys71 was also constructed but showed no pheno-
typic resistance to ampicillin and was not further charac-
terized (data not shown). 
Except for its increased sensitivity to alkaline pH and 
its thermal instability, the mutant Thr71-->Cys behaved sim-
ilarly to the wild-type enzyme during its purification, in 
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that the osmotic extrusion released activity from the cells 
into the extrudate. This indicates that processing and se-
cretion of the mutant is not severely affected by the pres-
ence of the additional cysteine six residues away from Cys77 
which is involved in a disulfide bond with Cysl23. Assuming 
KM reflects the intrinsic binding constant of substrate to 
the enzyme, binding is not significantly changed relative to 
the wild-type enzyme, indicating no gross structural changes 
occurred. The mutant Ser70-->Cys shows similar reductive 
behavior on treatment with OTT as the wild-type enzyme (27). 
The Thr71-->Cys mutant shows appreciable catalytic ac-
tivity on penams and cephems, as shown in Table 1. The mu-
tant does not hydrolyze 6-aminopenicillanic acid with as high 
an efficiency as it does benzylpenicillin and its catalytic 
efficiency on cephalothin is even poorer. Due to the thermal 
instability of the mutant and the necessity of exposing it to 
room temperature during the ammonium sulfate precipitation 
step, the absolute values for kcat may contain a systematic 
error due to limited thermal denaturation but since the 
kinetic parameters were all obtained over a two day period 
the relative rates of catalysis on the different substrates 
should be accurate. The lower efficiency of catalysis on 
cephalothin is consistent with that seen with other mutants 
at position 71 (10,11) and may reflect a more stringent pro-
tein structural requirement for turnover of cephems. The KM 
for cephalothin for both the mutant and wild-type enzymes is 
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about ten times that for benzylpenicillin. Thus, the binding 
orientation of cephems to the class A B-lactamase is not op-
timal for catalysis and is even less so for mutants at po-
sition 71. The molecular basis for the decreased effici-
ency of catalysis of 6-APA is not clear but may be due to an 
interaction between the positive charge of the amino group of 
the substrate and the sulfhydryl group of the Cys71. The 
decreased efficiency of the mutant on 6-APA is reflected in 
its phenotypic behavior. Cells harboring pBR322T71C grow as 
well as cells containing the wild-type enzyme on all other 
concentrations of antibiotics but will only grow on up to 100 
mg/L 6-APA at 37°C where the wild-type is resistant to con-
centrations in excess of 250 mg/L (9). 
Replacing Thr71 with Cys generates a mutant with several 
novel properties. As the pH of the assay buffer becomes more 
basic the mutant shows a more rapid decrease in activity com-
pared to the wild-type which does not begin to show a sub-
stantial decrease in activity until the pH is above 8.4. The 
midpoint of activity loss for the mutant is about pH 8 and 
since the pKa of cysteine is 8.33 the loss of activity prob-
ably reflects the development of anionic character of the 
sulfhydryl adjacent to the active site serine. The value of 
KM increases from 40 to 166 µM from pH 7 to 8.1 for the 
mutant on benzylpenicllin. The value of KM for the wild-type 
also increases over the same pH range from 20 to 67 µM (28). 
If KM is assumed to reflect the intrinsic binding constant of 
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substrate to enzyme the larger increase for the mutant may 
mean a conformational change associated with the anionic 
character of the sulfhydryl of Cys71. The decrease in kcat 
of the mutant over that pH range may result from the conform-
ational change or from the effect of the anion adjacent to 
the active site serine on the nucleophilicity of the serine 
hydroxyl. Of interest is the decrease in kcat and increase 
in KM of the mutant Ser70-->Cys at basic pH, although the 
change is less dramatic and occurs at the same pH as for the 
wild-type enzyme (27). By contrast, thiolate anion is more 
reactive towards benzylpenicillin at higher pH (29). A 
change in the surface charge of a mutant of subtilisin (Asp99 
-->Ser), a distance of 14-15 A from the catalytic triad, 
changed the pH dependence of enzymatic activity, decreasing 
catalytic efficiency. The authors concluded the change was 
due to long range electrostatic effects (32). 
Phenotypic data on the resistance of mutants Thr71--> 
Asp and Thr71-->Glu are consistent with the incompatibility 
of an anion adjacent to the active site serine. Thr71-->Asp 
shows no phenotypic resistance to any antibiotic tested. 
However, Thr71-->Glu with the additional methylene group 
acting as a spacer shows appreciable growth on low levels of 
benzylpenicillin (9). 
Another novel property of the Thr71-->Cys mutant is its 
sensitivity to inactivation by the organic mercurial reagent, 
pCMB at concentrations where the activity of wild-type B-
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lactamase is not affected. This result indicates the side 
chain of the residue adjacent to the active site is available 
to reaction with small molecules and that covalent incorpor-
ation of the bulky pCMB group in the active site causes 
inactivation, probably by sterically preventing the binding 
of substrate or by causing a conformational change. The 
almost complete loss of activity suggests the activity assoc-
iated with the Cys71 mutant is due to the mutant and not to 
contamination by the wild-type enzyme. 
The thermal stability of the mutant is decreased rela-
tive to that of the wild-type. The cysteine side chain 
substitutes a sulfhydryl group for the hydroxyl of threonine 
and does not have the corresponding methyl group. The mutant 
Thr71-->Ser has been shown to be less thermally stable than 
the wild-type and is also more easily denatured in the pre-
sence of urea (10). Therefore the methyl group also con-
tributes to the thermal stability of the enzyme. The overall 
energy of stabilization of a protein is in the range of 10-40 
kcal/mole (30). The loss of 2-5 kcal/mole of stabilization 
energy from the hydrogen bonding of the hydroxyl and favor-
able hydrophobic interactions of the methyl group represents 
a substantial fraction of the overall energy of stabilization 
and leads to the observed thermal instability of the mutant. 
In an interesting contrast the Ser70-->Cys mutant shows a 3-
fold greater resistance to inactivation by trypsin at 40°C, 
which infers an 0.6 kcal/mole greater energy of stabilization 
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compared to wild-type enzyme. The authors concluded the 
greater stability was due to replacing an hydroxyl group with 
the sulfhydryl group in the apolar interior of the enzyme 
( 27) • 
Borate ion competitively inhibits both the wild-type and 
mutant B-lactamases with Kr's of 1 and 2.5 mM respectively. 
Borate also competitively inhibits the Thr71-->Ser mutant 
with a Kr of 1 mM but only noncompetitively inhibits the 
Ser70-->Cys mutant at high borate concentrations. There-
fore interaction of borate with the active site hydroxyl is 
required for competitive inhibition but some interaction with 
the hydroxyl on the adjacent residue may occur lowering the 
inhibition constant. Alternately, the Kr of borate may be 
increased in the mutant because of electrostatic interactions 
between the sulfhydryl of Cys71 and the negatively charged 
borate ion. 
Summary 
Replacing the conserved threonine residue adjacent to 
the active site serine of RTEM-1 B-lactamase with a cysteine 
by cassette mutagenesis generates a mutant with several novel 
properties. The mutant shows phenotypic resistance to B-
lactam antibiotics. The efficiency of catalysis of the 
mutant is reduced relative to the wild-type to 12% on ben-
zylpenicillin, 3% on cephalothin, and 9% on 6-APA. The 
mutant is much more sensitive to activity loss at alkaline 
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pH, losing 50% activity at about pH 8.1, than the wild-type 
which loses 50% of its activity at about pH 9. The activity 
loss is probably due to the development of anionic character 
at the sulfhydryl causing a small conformational change or 
affecting the ionic character of the active site. The mutant 
is sensitive to inactivation by pCMB under conditions where 
the wild-type enzyme is not affected. The mutant is substan-
tially less thermally stable than the wild-type enzyme sug-
gesting the methyl group and the hydroxyl group of the wild-
type threonine are important for stability of the enzyme 
though not required for catalysis. Borate ion inhibits both 
the wild-type and mutant enzymes although the Kr for the 
mutant is slightly elevated. 
45 
References 
1. Datta, N., and Kontomichalou, P. (1965) Nature (London) 
208, 239-241. 
2. Ambler, R. P. (1980) Phil. Soc. Trans. R. Soc. Lond. 
Ser. B 289, 321-331. 
3. Bicknell, R., and Waley, S.G. (1985) Biochemistry 24, 
6876-6887. 
4. Jaurin, B., and Grundstrom, T. (198l)Proc. Nat'l. Acad. 
Sci. USA 78, 4897-4901. 
5. Knott-Hunziker, V., Peturrson, s., Waley, s. G., Jaurin 
B., and Grundstrom, T. (1982) Biochem. J. 207, 315-322. 
6. Pratt, R. F., and Loosemore, M. J. (1978) Proc. Nat'l. 
Acad. Sci. USA 75, 4145-4149. 
7. Knott-Hunziker, v., Orlek, B., Sammes, P. G., and Waley 
s. G. (1979) Biochem. J. 177, 365-367. 
8. Knott-Hunziker, V., Waley, S.G., Orlek, B., and Sammes, 
P. G. (1979) FEBS Lett. 99, 59-61. 
9. Schultz, s. c., and Richards, J. H. (1986) Proc. Nat'l. 
Acad. Sci. 83, 1588-1592. 
10. Dalbadie-McFarland, G., Neitzel, J., and Richards, J.H. 
(1986) Biochemistry 25, 332-338. 
11. Chang, Y.-H. (1986) Ph.D. thesis, California Institute 
of Technology. 
12. Boyer, H. w., and Roulland-Dussoix, D. (1969) J. Mol. 
Biol. 41, 459-472. 
46 
13. Beaucage, s. L., and Caruthers, M. H. (1981)Tetrahedron 
Lett. 22, 1859-1862. 
14. Ish-Horowicz, D., and Burke, J. F. (1981) Nucleic Acids 
Res. ~, 2989-2998. 
15. Maniatis, T., Fritsch, E. F., and Sambrook, J. (1982) 
Molecular Cloning; a Laboratory Manual (Cold Spring 
Harbor Laboratory, Cold Spring Harbor, NY). 
16. Hanahan, D. (1983) J. Mol. Biol. 166, 557-580. 
17. Maxam, A. M., and Gilbert, w. (1980) Methods in Enzymol 
65, 499-560. 
18. Fisher, J., Belasco, J.G., Khosla, s., and Knowles, 
J.R. (1980) Biochemistry 19, 2895-2901. 
19. Fisher, J., Belasco, J.G., Khosla, s., and Knowles, 
J. (1980) Biochemistry 19, 2895-2901. 
20. Amann, E., Brosius, J., and Ptashne, M. (1983) Gene 25, 
167-178. 
21. DeBoer, H. A., Comstock, L. J., and Vasser, M. (1983) 
Proc. Nat'l. Acad. Sci. USA 80, 21-25. 
22. Laemmli, U. K. (1970) Nature (London) 227, 680-685. 
23. Lineweaver, H., and Burk, D. (1934) J. Am. Chem. Soc. 
56, 658-666. 
24. Lee, H.-J., and Wilson, I. B. (1971) Biochim. Biophys. 
Acta 242, 519-522. 
25. Kiener, P.A., and Waley, s. G. (1978) Biochem. J. 169, 
197-204. 
26. Sigal, I. s., Harwood, B. G., and Arentzen, R. (1982) 
47 
Proc. Nat'l. Acad. Sci. USA 79, 7157-7160. 
27. Sigal, I. s., DeGrado, W. F., Thomas, B. J., and 
Petteway, s. R. (1984) J. Biol. Chem. 259, 5327-5332. 
28. Kemal, c., and Knowles, J. R. (1981) Biochemistry 20, 
3688-3695. 
29. Nakken, K. F., Eldjarn, L., and Pihl, A. (1960) Biochem 
Pharmacol 1, 89-100. 
30. Crampton, d., as cited in 31. 
31. Matsumara, M., Yasumura, s., and Aiba, s. (1986) Nature 
323, 356-258. 
32. Thomas, P.G., Russell, A.J., and Fersht, A.R. (1985) 
Nature (London) 318, 375-376. 
48 
Figure 1 
Three fragment ligation scheme 
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Hybridization screening of plasmid containing the mutation 
AGC-->TGT in codon 71 of the B-lactamase gene 
A. Agarose gel electrophoresis of EcoRI digests of plasmid 
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B. Autoradiogram of the hybridization of a mutagenic probe to 
a nitrocellulose replicate of A., room temperature wash 
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Figure 4 
DE-52 column profile of the purification of 
mutant Thr71-->Cys (•-activity, o-A2a1) 
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Figure 5 
Activity vs. pH for Thr71-->Cys (o) and for wild-type (•) 
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Table 1. Kinetic Parameters 
Thr71-->Cys (wild-type) 
470±45 (2000) 40±10 (20) 
13±1 (120) 690±60 (190) l.9x104 (6x105) 






















Thermal stability of wild-type and Thr71-->Cys 















Kinetic parameters at pH 8.1 













studies of the relationship between the linear sequence 
of amino acids of a protein, its three-dimensional structure 
and its function have been greatly facilitated by the advent 
of site-directed mutagenesis (1,2,3). This technique allows 
the introduction of a specific change in the linear sequence 
of the protein. Differences in the structure or function of 
the mutagenized protein can then be ascribed to the single 
mutation. 
Oligonucleotide-directed mutagenesis has been used to 
study the roles of individual residues in catalysis by 
several enzymes. The contributions of the side chains of 
active site residues to the binding energy of substrate and 
the effect of changes in binding energy on catalysis have 
been investigated in a series of mutations of tyrosyl tRNA 
synthetase (4-7). Amino acid residues of cytochrome c 
previously thought to be necessary for electron transfer were 
found to be nonessential (8). The active site serine of 
alkaline phosphatase was changed to cysteine and the 
resulting mutant retained 2-10% of the wild-type activity, 
depending on the substrate (9). Oligonucleotide-directed 
mutagenesis has also been used to study lac carrier protein 
(10), aspartate transcarbamoylase (11), triose phosphate 
isomerase (12), and B-lactamase (13). 
Mixtures of oligonucleotides have been used to generate 
more than one mutation at a time (14,15,16). However, a more 
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efficient method for simultaneously generating more than one 
mutant either at the same site or at different positions of 
the same protein is cassette mutagenesis (17,18). With this 
technique a cassette of duplex oligonucleotides that may 
contain a mixture of codons at one or more positions is 
ligated between two restriction sites flanking the region of 
interest. Cassette mutagenesis has been used to generate all 
nineteen mutations at a single site in B-lactamase (17) and 
in subtilisin (18). The specificity of DNA binding of the 
434 repressor was converted to that of the P22 repressor by 
substituting five amino acids of the P22 sequence for the 
corresponding amino acids of the 434 repressor along a 39 bp 
duplex sequence by cassette mutagenesis (19). Cassette 
mutagenesis was used to investigate the role of the 5' ends 
of mRNA in the CYCl gene of Saccharomyces cerevisiae (20). 
Cassette mutagenesis becomes even more rapid and power-
ful when applied to a system with a convenient phenotypic 
screen. Large numbers of mutants may be generated simultan-
eously and then screened for a particular function. Mutants 
of interest can be selected on the basis of their phenotypic 
behavior and investigated further. The existence of a phen-
otypic screen for enzymatic activity of B-lactamase makes it 
a convenient system for such studies using cassette mutagen-
esis. 
Class A B-lactamases, of which the RTEM-1 enzyme is a 
member, maintain a conserved triad of amino acids, Ser-Thr-
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xaa-Lys, where the serine is the active site nucleophile (21-
24). The role of the conserved Thr has been investigated 
using oligonucleotide-directed mutagenesis (25,26), and cas-
sette mutagenesis (17). Thr71 of RTEM-1 B-lactamase appears 
to be conserved more for reasons of protein stability and 
less importantly for catalysis or substrate binding. A Lys 
residue three amino acids to the carboxy side of the active 
site Ser is conserved not only in Class A B-lactamases but 
also in Class C B-lactamases, the related D,D-carboxypepti-
dases-transpeptidases, and in all higher molecular weight 
penicillin-binding proteins sequenced to date (21,27,28). 
This fact alone suggests a critical role for this conserved 
lysine. Data from chemical modification experiments using 
methyl acetimidate indicate the existence of an essential 
amino group that is protected from reaction by the presence 
of substrate (29). Inactivation by phenylpropynal (30) and 
phenylglyoxal (31) is consistent with an essential lys or 
arg. Studies of the inactivation of B-lactamase by the 
mechanism-based inactivators penicillanic acid sulfone (32), 
clavulanic acid (33) and 6-acetylmethylene penicillanic acid 
(34) indicate the involvement of a nucleophile other than the 
serine close to the active site. The conserved lysine is a 
logical possibility for such a nucleophile. 
This chapter describes the use of cassette mutagenesis 
to replace the conserved lysine of RTEM-1 B-lactamase with 
the other nineteen amino acids. A duplex synthetic oligo-
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nucleotide containing a mixture of codons in place of the 
lysine codon was ligated to restriction fragments of pBR322. 
The ligation mixture was used to transform ~ coli to tetra-
cycline resistance. Plasmids derived from one hundred TetR 
colonies were sequenced. Due to an uneven mixture of bases 
in the mixed codon the mutants Lys73-->Asp, Glu and Pro were 
not located and were constructed separately. None of the 
nineteen mutants conferred resistance to cells to low levels 
of ampicillin. Western blot analysis of whole cell extracts 
showed each of the mutants was present in the cells in 
amounts comparable to the wild-type enzyme. 
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Materials and Methods 
Enzymes and Chemicals 
Restriction enzymes and the large (Klenow) fragment of 
DNA ploymerase I were purchased from Boehringer Mannheim. T4 
polynucleotide kinase and T4 DNA ligase were from Bethesda 
Research Laboratories. Antibiotics were obtained from Sigma 
Chemical Co. The [~-32P]dTTP, 3000 ~Ci/mmol was obtained 
from Amersham, and the [~-32P]ATP was from ICN. All other 
chemicals used were reagent grade. 
DNA 
Oligonucleotides were synthesized by using the 
phosphoramidite chemistry (35) on the Applied Biosystems 
(Foster City, CA) DNA synthesizer, model 380A and purified by 
preparative polyacrylamide gel electrophoresis, followed by 
desalting by G-25 chromatography. The mixed codon was syn-
thesized by using an equimolar mixture of the four nuleotide 
phosphoramidites or an equimolar mixture of G and c phosphor-
amidite in a normal coupling reaction. 
DNA fragments were purified from 1.2% agarose gels using 
either DEAE-cellulose paper or an International Biotechnol-
ogies, Inc. (New Haven, CT) UEA electroeluter. 
Plasmid DNA was prepared by the alkaline lysis method 
(36). The numbering system for pBR322 is the one commonly 
used (37). ~ coli strain LSl (38) was used as host for 
pBR322 and its derivatives. 
Reactions and Mutagenesis 
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The complementary mutagenic oligonucleotides were phos-
phorylated using standard procedures (37), and were annealed 
by mixing 0.4 pmole/µL of each strand and heating to 95°C in 
10 mM MgC1 2 , 50 mM Tris-HCl, pH 8, followed by slow cooling 
over a one hour period to room temperature. 
The three fragment ligation scheme was used to generate 
the mutants (17). The mutagenic oligonucleotides shown in 
Figure 2 were kinased and annealed as described. For the 
ligation approximately 0.04 pmole of each restriction frag-
ment and 0.4 pmole of the synthetic fragments were mixed in 
10 mM MgC1 2 , 50 mM Tric-HCl, pH 8, 0.5 mM ATP, 5 mM dithio-
threitol and 10 units of T4 ligase and incubated at 15°C for 
approximately 16 hours. The ligation was terminated by 
heating to 60°C for 10 minutes and a 10 ~L aliquot was used 
to transform ~ coli LSl to tetracycline resistance, using 
standard transformation procedures (39). 
Growth on antibiotics 
Transformation resulted in approximately 450 TetR col-
onies. One hundred of these were picked with sterile tooth-
picks onto defined positions on L agar plates containing 
either 15 ~g/mL tetracycline or 25 ~g/mL ampicillin and 
incubated at 37°C for 12 to 16 hours. Thirteen of the one 
hundred colonies grew on ampicillin. Plasmid was purified 




Plasmid was digested with AvaI restiction endonuclease 
and the resulting 2962 bp fragment isolated as described 
before. The fragment was labeled at nucleotide T-3973 using 
[a-32P]dTTP and the large (Klenow) fragment of DNA poly-
merase I, as shown in Figure 2. The labeled fragment was 
precipitated from the polymerase solution with 2.5 volumes of 
ethanol and pelleted by centrifugation. The pellet was 
washed with 70% ethanol and dried in a Speedvac. The labeled 
fragment was sequenced by the method of Maxam and Gilbert 
(40). The sequencing gels were 40 cm long and contained 20% 
polyacrylamide (w/v) and 40% urea (w/v) and were run using 
standard conditions (37). 
Western blotting 
Cells containing plasmids for each of the nineteen mut-
ations were grown to late log phase in LB broth with 15 µg/mL 
tetracycline. One ml of cells was pelleted by centrifugation 
and resuspended in 50 µL of SOS-PAGE sample buffer (10% (v/v) 
glycerol, 3% (w/v) sodium dodecyl sulfate, 62.5 mM Tris-HCl, 
pH 6.8, 1 mM EDTA, 0.1 % bromphenol blue) and lysed by incub-
ation in boiling water for 10 minutes. Aliquots of 20 ~L 
were loaded onto a 15 cm 12% polyacrylamide gel with a 2 cm 
3.5% stacking gel and electrophoresed for 12 to 16 hours at 5 
mA until the dye had run off the gel . 
The protein was transferred from the gel to nitrocellu-
lose (BASS, Schleicher and Schuell) using a Biorad Transblot 
cell. The gel was soaked in transblot running buffer (25 mM 
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glycine, 193 mM Tris, 20% methanol, pH 8.3) for 20 minutes. 
The gel was then sandwiched between the nitrocellulose and 
Whatmann No. 1 filter paper and electrophoresed for 5 to 7 
hours at 40 to 60 volts. 
B-lactamase was visualized using a staining system based 
on anti-B-lactamase antibody. After electrophoresis the 
nitrocellulose was washed in a solution of TPBS (10 mM sodium 
phosphate, 0.9% NaCl, pH 7.5, 0.05% Tween 20), 1% normal goat 
serum, 1% BSA for 12 hours at room temperature. The nitro-
cellulose was rinsed with TPBS and then transferred to a 
solution containing TPBS and a 1:1000 dilution of primary 
anti-B-lactamase antisera. The antisera was the generous 
gift of J. Neitzel, and was raised in rabbits by injection of 
complete Freund's adjuvant containing denatured B-lactamase 
that had been purified from a SDS-PAGE gel(25). Subsequent 
booster shots were made with B-lactamase purified as des-
cribed (25). The nitrocellulose was then stained using a 
Vectastain ABC kit (Vector Laboratories, Burlingame, CA), 
according to the manufacturer's instructions (41). 
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Results 
The three fragment ligation scheme used to generate 
mutants of B-lactamase at position 73 is illustrated in 
Figure 1 of Chapter 2. One sample of plasmid pBR322ss was 
digested with AvaI and SalI restriction endonucleases and the 
1042 bp fragment was isolated. Another sample of plasmid was 
digested with SalI and ScaI restriction endonuclease and the 
resulting 2692 bp fragment was isolated. The purified frag-
ments were mixed with the annealed, kinased oligonucleotides 
shown in Figure 1 and ligated by the addition of T4 DNA li-
gase. The resulting ligation mixture was used to transform 
~ coli LSl to tetracycline resistance, generating approxi-
mately 450 transformants. Of these 100 were picked with 
sterile toothpicks onto defined positions of L agar plates, 
containing either 15 mg/L tetracycline or 25 mg/L of am-
picillin. Thirteen of the one hundred colonies grew on 
ampicillin. 
Figure 3 in Chapter 2 describes the labeling scheme used 
for DNA sequencing. Plasmid derived from each of the 100 
colonies was digested with AvaI restriction endonuclease and 
the 2962 bp fragment was isolated. Since AvaI restriction 
endonuclease leaves assymmetric overhangs, it was possible to 
label the fragment assymmetrically by adding radioactive T to 
one end with the Klenow enzyme. To suppress the 3'-5' endo-
nuclease activity of the Klenow enzyme from digesting the 
opposite end of the fragment and exposing an A which could 
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lead to labeling of that end and confusion of the sequencing, 
a small amount of dGTP was added to the labeling reaction. 
The sequences of the mixed codon from the 100 colonies 
are shown in Table 1. All thirteen of the colonies resis-
tant to ampicillin contained lysine at position 73. Five of 
those contained the wild-type codon for Lys, TTT, and the 
remainder contained the codon TTC resulting from the incor-
poration of the synthetic oligonucleotides. All colonies 
containing the codon for lysine at position 73 were resis-
tant to ampicillin. None of the colonies containing codons 
for other amino acids at position 73 were resistant. 
The quality of the oligonucleotide synthesis is evi-
denced by the low frequency of point mutations in the syn-
thetic sequence. Two transition errors, one insertion error 
and one deletion error were found. Seven of the one hundred 
colonies contained deletions at the initial base of the Scar 
restriction fragment, probably the result of incorrect 
digestion by Sea! restriction endonuclease, and incorporation 
of the blunt end. 
The mixed codon of the synthetic oligonucleotides did 
not contain an even mixture of the four bases. In the first 
two positions, A and T were present twice as often as G and 
c. Zon, et al (42), have shown that the G phosphoramidite 
decomposes more rapidly than the other three base phosphor-
amidi tes. Since the synthesis is done by adding equal 
amounts of all four phosphoramidites, a lower amount of G in 
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the synthesis will result in fewer G-containing oligonucleo-
tides. When the complementary strands are annealed for 
ligation into the vector, the number of oligonucleotides 
containing G in the mixed codon will limit the complementary 
c-containing oligonucleotides resulting in a comparably lower 
percentage of C in the mixed codon as is observed in Table 
2. Because of the uneven percentages of the bases in the 
mixed codon, not all twenty amino acids were found in the 
first one hundred colonies. Lys73-->Asp, Glu and Pro were 
not found and were constructed separately using the oligonuc-
leotides shown in Figure 1, and the same three fragment 
ligation scheme. 
To determine if cells harboring mutated plasmids pro-
duce B-lactamase protein, western blots were run. The 
results are shown in Figures 2, 3, and 4. All nineteen 
single amino acid replacements had little apparent effect 
on the intensity of the staining of the B-lactamase band of 
these blots, demonstrating the mutants were produced in 
amounts comparable to the wild-type enzyme and were of com-
parable stability. LSl cells without plasmid showed no band 
corresponding to B-lactamase. The presence of unidentified 
proteins from ~ coli that cross-react with the anti-B-lac-
tamase antibody serves as a useful internal control demon-
strating that comparable amounts of the extracts were loaded 
onto each lane of the gel. 
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Discussion 
Cassette mutagenesis is an enormous improvement in mut-
agenic techniques because it provides a rapid, efficient 
method for the production of one or more mutants at one or 
more positions across a segment of a gene. The size of the 
segment is determined by the placement of convenient unique 
or nearly unique restriction sites and the limit of effi-
cient synthesis of oligonucleotides, typically one hundred 
bases or less. In this work, cassette mutagenesis has been 
used to generate nineteen amino acid replacements and one 
amber mutation at the 73rd amino acid of B-lactamase. 
The quality of the oligonucleotide synthesis is of 
paramount importance when using cassette mutagenesis to pro-
duce more than one mutation simultaneously. Of the one 
hundred plasmids sequenced only four contained errors in the 
synthetic oligonucleotides: one insertion, one deletion and 
two transversions. By contrast, in the production of twenty 
mutants of subtilisin approximately 30% of the plasmids 
sequenced contained errors (18). Seven deletion errors at 
the initial base of the ScaI-SalI restriction fragment were 
found, probably the result of incorrect restriction by ScaI 
endonuclease or incorrect ligation. Similar deletions were 
observed in the ligation of synthetic DNA into the PstI site 
of the subtilisin gene (18). 
Close to equimolar ratios of the four bases at the 
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position of the mixed codon are required for easy, rapid 
location of the twenty mutants if a site is to be saturated. 
This requirement is even more stringent if saturation is to 
be extended to two or more sites simultaneously to ensure 
production of all permutations of amino acids at the two 
sites. Unfortunately the mixed codon of the oligonucleo-
tides used to saturate Lys73 did not contain an even mixture 
of all four bases. The ratio of A and T to G and C was about 
2:1 in the first two positions of the mixed codon. The 
reason for the uneven mixture probably is the reported 
greater instability of the G phosphoramidite (39). Since c 
will be opposite G in the complementary strand the lower 
amount of G will be the limiting factor reducing the number 
of c-containing sequences. Because of the uneven mixture of 
bases in the mixed codon only 25 of the 32 codons were found 
(Table 4) and not all twenty amino acids were found in the 
first one hundred colonies; accordingly the mutations Lys--> 
Asp, Glu and Pro were made separately. The third position of 
the mixed codon contained only G and c since this cuts in 
half the number of codons produced without eliminating any 
amino acid and also provides a means of distinguishing 
between the Lys codon of the wild-type sequence (AAA) and 
that of the synthetic oligonucleotides (AAG) . 
several factors can effect the level of phenotypic 
resistance to antibiotics including plasmid copy number, 
transcription, mRNA stability, secretion and processing of 
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pre-B-lactamase, thermal stability, stability to native 
proteases, and enzymatic activity. Plasmid copy number is 
controlled by a region of the plasmid far removed from the 
site of mutation. Additionally no significant change in the 
yield during plasmid purification for sequencing was ob-
served. Codon usage can effect the level of translation 
(43). However all of the codons found at the site of muta-
tion except that for Phe are used elsewhere in the B-lacta-
mase gene (44). Western blotting shows that all nineteen 
mutants were present in cell extracts at levels comparable to 
the level of wild-type enzyme indicating that the stability 
of the mutants to thermal denaturation and proteolysis is not 
significantly affected. Western blotting also shows, at least 
in most lanes, a faint band 2-3 kdaltons above the B-lacta-
mase band that is absent in the LSl extract. This band 
probably corresponds to pre-B-lactamase and, since it stains 
only faintly compared to the B-lactamase band, it infers that 
most of the preprotein is processed correctly. Mutations may 
effect the secretion of the protein, as is the case with mal-
tose binding protein (43). Mutants Thr71-->Ser and Ser70--> 
Thr are processed and secreted normally in ~ typhimurium 
(25). The mutant Cys77-->Ser is also secreted normally (46). 
The inherent enzymatic activity of the mutants is there 
fore the most likely reason for the absence of phenotypic 
resistance to B-lactam antibiotics. The Ser70-->Cys mutant 
maintains 1-2% of the wild-type activity on ampicillin and 
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shows phenotypic resistance to the antibiotic at a concentra-
tion of 10 mg/L which is approaching the selection limit. A 
mutant showing approximately 0.1% of the wild-type activity 
on ampicillin is not phenotypically active (26). Thus, if 
one assumes the stability and production of the mutant and 
wild-type proteins are equivalent, the activity cutoff for 
phenotypic selection on ampicillin falls somewhere between 
0.1 and 1% of the activity of the wild-type enzyme. Presuma-
bly, the activity all of the mutants at Lys73 is below this 
cutoff value. 
Such a drastic reduction in catalytic efficiency is not 
without precedent in mutagenesis. The mutant Thr71-->Ile of 
the B-lactamase from ~ aureus PCl is inactive (47). Struc-
tural studies of the mutant indicate that it is improperly 
folded. A mutant of tyrosyl tRNA synthetase with efficien-
cies less than 1/105 that of the wild type enzyme has been 
constructed (48). A mutant of dihydrofolate reductase, 
Leu54-->Gly, shows a io4-fold reduction in the rate of hyd-
ride transfer (50). 
A reduction in catalytic efficiency of 103 or greater 
compared to the wild-type enzyme may still mean the mutants 
are true enzymes. catalysis is defined by an enhancement of 
the rate over the background rate and the turnover of more 
than one molecule of substrate per enzyme molecule. The 
background hydrolysis rate for benzylpenicillin at pH 7 is 
0.2 M-1 sec-1 (49). The wild-type catalyzes the hydrolysis 
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of benzylpenicillin with an efficiency of 108 M-lsec-1. 
Therefore a reduction of three orders of magnitude would 
still mean a rate enhancement of 106 over the background 
rate. 
Summary 
The lysine residue at position 73 of RTEM-1 B-lactamase 
has been replaced by the other nineteen amino acids and an 
amber stop codon by cassette mutagenesis. Due to an uneven 
mixture of bases at the mixed codon not all nineteen mutants 
were located in the first one hundred plasmids that were 
sequenced. Therefore the mutants Lys73-->Asp, Glu and Pro 
were constructed separately by cassette mutagenesis. None of 
the mutants confer to cells resistance to low levels of 
ampicillin indicating a reduction in catalytic efficiency to 
at most 1% that of the wild-type enzyme. Western blots of 
whole cell extracts indicate that all nineteen mutants are 
produced in the cell in amounts comparable to the wild-type. 
Therefore the lack of phenotypic resistance to B-lactam 
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Oligonucleotides used for mutagenesis 
1. Oligonucleotides used for the attempted saturation 
2. Oligonucleotides used to create the mutant Lys73-->Pro 
3. Oligonucleotides used to create the mutants Lys73-->Asp, 
Glu 
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5 1 CC GAG GAA CGT TTT CCA ATG ATG 
C CTT GCA AAA GGT TAC TAC 
2. 
AGC ACT TTT l~C~ GT 
TCG TGA AAA GGG CA 5 1 
TT 
5 1 CC GAG GAA CGT TTT CCA ATG ATG AGC ACT TTT CCG GT 3 1 
C CTT GCA AAA GGT TAC TAC TCG TGA AAA GGC CA 5 1 
3. 
5 1 CC GAG GAA CGT TTT CCA ATG ATG AGC 
C CTT GCA AAA GGT TAC TAC TCG 
ACT TTT [GA~J GT 3 1 
TGA AAA CTG CA 5 1 
c 
89 
Table 1. Sequences of the mixed codon 
Sequence Amino 
Number Sequence Acid Active Comment 
1. CAC His 
2. TTC Phe 
3. AGC Ser 
4. ACC Thr 
5. AAA Lys x 
6. TTC Phe 
7. GGG Gly 
8. ATG Met a 
9. CAG Gln b 
10. AAG Lys x 
11. ATG Met 
12. GTC Val 
13. GGG Gly 
14. TGC Cys 
15. TCG Ser c 
16. TGC Cys c 
17. GTC Val 
18. TCG Ser 
19. TGG Trp 
20. AAA Lys x 
21. AAG Lys x 
22. AAG Lys x 
23. CGC Arg 
24. ATG Met 
25. AAA Lys x 
26. AAA Lys x 
27. AAG Lys x 
28. AAG Lys x 
29. AAG Lys x 
30. AAG Lys x 
31. AAA Lys x 
32. TTC Phe 
33. CTC Leu 
34. GTC Val 
35. AAG Lys x 
36. GTC Val 
37. GCC Ala 
38. TAC Tyr d 
39. AGC Ser 
40. TGC Cys 
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Table 1, continued. 
Sequence Amino 
Number Sequence Acid Active Comment 
41. ACC Thr 
42. ATC Ile b 
43. CTC Leu 
44. CTC Leu 
45. TAG Stop c 
46. GGG Gly c 
47. TAC Tyr 
48. TAC Tyr 
49. GTC Val 
50. TCG Ser c 
51. TAC Tyr 
52. ? 
53. ? 
54. CAG Gln 
55. A?C 
56. TTC Phe 
57. GGG Gly 
58. AAC Asn 
59. AAC Asn 
60. AAC Asn 
61. TCG Ser 
62. TTC Phe 
63. ATG Met 
64. TCG Ser 
65. CAG Gln 
66. TTG Leu 
67. ? 
68. CTC Leu 
69. TCG Ser 
70. ATC Ile 
71. GAG Glu c 
72. ? 
73. GCC Ala 
74. CGC Arg 
75. AGG Arg c 
76. GTC Val 
77. GCC Ala 
78. TAC Tyr 
79. AAC Asn 
80. TAC Tyr 
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Table 1, continued. 
Sequence Amino 
Number Sequence Acid Active Comment 
81. TTG Leu 
82. CAC His 
83. TAG Stop 
84. ? 
85. TAC Tyr 
86. C?G 
87. ATC Ile 
88. CTG Leu 
89. AAC Asn 
90. TAC Tyr 
91. ? 
92. ? 
93. TAG Stop 
94. TAC Tyr 
95. TCG Ser 
96. TCG Ser 
97. AAC Asn 
98. CCG Pro 
99. GAC Asp 
100. GAG Glu 
comments-
a- transversion error 
b- deletion error 
c- deletion at ScaI site 
d- insertion error 
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Table 2. Percentages of bases in mixed codon. 
Position 
First Second Third 
A 34 44 
T 36 26 
G 17 15 43 
c 13 15 56 
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Table 3. Mutants chosen for Western Blotting 
Amino Acid Codon Growth on 25 mg/L 
Ampicillin 
Lys AAA(wildtype) +++ 
Lys AAG +++ 
Arg CGC 0 
His CAC 0 
Trp TGG 0 
Tyr TAC 0 
Phe TTC 0 
Ser TCG 0 
Thr ACC 0 
Cys TGC 0 
Met ATG 0 
Asp GAC 0 
Glu GAG 0 
Asn AAC 0 
Gln CAG 0 
Ala GCC 0 
Gly GGG 0 
Ile ATC 0 
Leu CTC 0 
Val GTC 0 
Pro CCG 0 
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Table 4. Codons found 






















































ACG GTG GGC GCG CGG CCC TCC 
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Figure 2 
Western Blots of whole cell extracts containing the indicated 
mutants of B-lactamase at position 73. The blots were 
stained according to the procedures described in the 
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Purification and Characterization 
of Two Mutants of RTEM-1 B-lactamase 
at Lysine 73 
102 
Introduction 
B-lactamases catalyze the hydrolysis of the amide bond 
of the B-lactam ring of penam and cephem antibiotics (1). 
Two general mechanisms have been proposed for the catalytic 
mechanism of B-lactamases. The enzyme may act either through 
general acid-base catalysis directing the nucleophilic attack 
of water on the B-lactam ring or through attack by a nucleo-
phile of the enzyme itself on the B-lactam ring. The prepon-
derance of evidence with Class A B-lactamases suggests the 
existence of a covalent acyl-enzyme intermediate, consistent 
with direct nucleophilic catalysis by the enzyme. The first 
evidence for the acyl-enzyme intermediate came from studies 
of the hydrolysis of the poor substrate cefoxitin (kcat/KM = 
6 M-lsec-1) (2). The slow turnover of cefoxitin by the RTEM-
2 enzyme allowed the observation of the buildup and breakdown 
of a putative acyl-enzyme intermediate. Denaturation of the 
intermediate followed by gel filtration and Fourier transform 
IR spectroscopy led to the identification of the intermediate 
as containing an ester linkage. The existence of an acyl-
enzyme intermediate during the catalysis of the good sub-
strates dansyl-penicillin and dansyl-cephalosporin was proven 
by low temperature and pH studies (3,4). The active site 
serine nucleophile was identified by reaction with a mecha-
nism-based inactivator, 6-Bbromopenicillanic acid (5,6,7). 
Evidence for the involvement of other amino acids in 
catalysis by B-lactamases is sparse. Chemical modification 
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experiments have implicated most amino acid side chains as 
important in catalysis (9). Oligonucleotide-directed muta-
genesis experiments have concentrated on the conserved amino 
acids about the active site serine. Saturation mutagenesis 
of Thr71 of RTEM B-lactamase has shown it to be conserved 
more for protein stability than for catalysis (10,11). As 
discussed in Chapter 3 of this work, no other amino acid 
coded for by DNA can substitute for Lys73 of RTEM B-lacta-
mase and give rise to an enzyme that can impart to cells a 
phenotype resistant to low levels of ampicillin. 
Evidence that the conserved lysine is in the vicinity 
of the substrate binding site comes from x-ray crystallo-
graphic studies of a related carboxypeptidase. One of the 
proteins involved in bacterial cell wall biosynthesis is 
D-ala,D-ala carboxypeptidase, the enzyme responsible for 
cleaving the terminal D-ala from the crosslinking peptide and 
regulating the amount of crosslinking in the cell wall. 
D-ala,D-ala carboxypeptidase binds penicillin but deacylates 
only very slowly. A relatively detailed crystal structure of 
the carboxypeptidase from Streptomyces R61 has been solved 
(12). The significant similarities between the secondary 
structural characteristics of the carboxypeptidase and the 
best crystal structure of a B-lactamase, that of the enzyme 
from ~ licheniformis 749/c as shown in Figure lA, support 
the theory that the two enzymes are evolutionarily related 
(13,14). The similarities between the two structures and the 
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significant sequence homology also allow the use of the 
active site structure of the carboxypeptidase as a working 
model for that of the B-lactamase. D-ala,D-ala carboxypep-
tidases maintain a conserved triad, Ser-Xaa-Thr-Lys, about 
the active site serine (15). As shown in Figure lB the con-
served lysine is in the vicinity of the substrate binding 
site and is apparently located on the opposite side of the 
bound substrate molecule from the serine. Thus the position 
of the conserved lysine may allow the interaction of its side 
chain with the bound substrate molecule. 
This chapter describes the purification and kinetic 
characterization of two of the mutants at position 73 of the 
RTEM-1 B-lactamase, Lys73-->Arg and Lys73-->Cys. These two 
mutants were chosen because arginine is the most conservative 
amino acid change from lysine and because cysteine is chemi-
cally versatile. The EcoRI-PvuI fragments of the two mutated 
genes were transferred to plasmid pJN for expression. Induc-
tion by the addition of IPTG allowed the easy identification 
by SOS-PAGE gel or western blotting of the position of mutant 
B-lactamases during the purification procedure. The Mich-
ealis-Menten parameters for benzylpenicillin were obtained 
and showed the mutations caused a 104 reduction in kcat for 
both mutants while KM was unchanged from the wild-type value. 
Lys73-->Arg was active on cephalothin but no activity was 
detected for Lys73-->Cys on cephalothin indicating that the 
positive charge of the side chain may help position the 
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bulkier cephems for acylation. Reaction of the Lys73-->Cys 
mutant with ethylenimine under mildly denaturing conditions 
caused the reactivation of the mutant after renaturation. 
The Lys73-->aminoethy1Cys derivative regained 62% of the 
efficiency of the wild-type enzyme on benzylpenicillin and 9% 
of the efficiency of the wild-type enzyme on cephalothin. 
These results prove that the amino group of the side chain of 
Lys73 of RTEM-1 B-lactamase is essential for efficient 
hydrolysis of penams and cephems but is not essential for 
binding of substrate. 
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Materials and Methods 
Enzymes and Chemicals 
Restriction enzymes were purchased from Boehringer 
Mannheim. T4 DNA ligase was obtained from Bethesda Research 
Laboratories. Antibiotics were from Sigma Chemical Co. 
Tryptone and yeast extract were from Difeo (Detroit, MI). 
Ethylenimine was synthesized from 2-aminoethyl hydrogen 
sulfate (Aldrich), according to published procedures (16). 
The fraction boiling at 95-100°C was collected and used 
immediately for the derivatization. Remaining stock 
ethylenimine was immediately destroyed by addition of B-
mercaptoethanol. 
Bacterial strains 
~ coli LSl (17) was used as host of plasmid pBR322 and 
the derivatives of pBR322. ~ coli D1210 was used as the 
host strain for plasmid pJN and is a lac Iq derivative of 
HBlOl. 
DNA 
DNA fragments were purified from 1.2% agarose gels using 
an International Biotechnologies, Inc. (New Haven, CT) UEA 
electroeluter. 
Plasmid DNA was prepared by the alkaline lysis method 
(18). The numbering system for pBR322 is the one commonly 
used (19). 
Subcloning into pJN 
Plasmids pBR322K73C and pBR322K73R and pJN were digested 
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with EcoRI and PvuI restriction endonucleases and the result-
ing 626, 626, and 4800 bp fragments isolated by electroelu-
tion, respectively. The 626 bp fragments of the two mutants 
were ligated separately to the 4800 bp fragment of pJN using 
procedures described above. Transformation of ~ coli 01210 
to kanamycin resistance was performed as described. To 
confirm the presence of the mutated gene, plasmid derived 
from a kanamycin resistant colony was digested with AvaI 
restriction endonuclease and run on a 1.2% agarose gel. The 
additional AvaI restriction site from plasmid pBR322ss was 
confirmed. 
Purification of Lys73-->Cys and Lys73-->Arg 
The purification scheme used was basically that de-
scribed in Chapter 2 but with a few minor modifications. 
Single colonies of ~ coli 01210 harboring plasmids 
pBR322K73C or pBR322K73R were used to inoculate 2 ml cultures 
of L broth containing 25 mg/L kanamycin which were grown to 
late log phase. one mL was used to inoculate a 250 mL 
culture of L broth containing 25 mg/L kanamycin which was 
incubated at 37°C with shaking for 8-10 hours. Fifty to 100 
mLs of the culture was used to inoculate 10 L of FB or XB 
media containing 25 mg/L kanamycin in a New Brunswick 
Magnaferm fermenter. The culture was grown at 37°C with 
vigorous aeration for 12-14 hours. IPTG was added to 0.1 rnM 
and induction continued at 37°C for from 20 to 75 minutes. 
Cells were harvested in a Beckman J-6B centrifuge at 2900 rpm 
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and were washed with 50 mM Tris, pH 7. The osmotic extrusion 
was performed as described (2). The ammonium sulfate 
precipitation was carried out as described in Chapter 2. The 
20-60% AS fraction was dialyzed against deionized, distilled 
water and concentrated to 30-50 mls in 25 mM triethanolamine, 
pH 7.25 (TEAC). The samples were then applied to a 2.5 by 30 
cm DE-52 column and eluted by using a linear gradient of from 
25 to 200 mM TEAC, pH 7.25. Mutant protein was located in 
the column fractions by either migration on SOS-PAGE gel, 
western blotting, or activity. Peak fractions were pooled 
and concentrated to 1-2 mls in either 20 mM Tris, pH 7, or in 
25 mM TEAC, pH 7.25. The samples in Tris were applied to a 1 
by 82 cm Ultragel ACA 54 column and eluted with the same 
buffer. The samples in TEAC were purified by FPLC using a 
Pharmacia Mono Q 5/5 column and the following discontinuous 
gradient. Buffer A is 25 mM TEAC, pH 7.25. Buffer B is 200 
mM TEAC, pH 7.25. At time o, 100% A; time 15 minutes, 85% A; 
time 40 minutes, 70% A. Flow rates were 0.8 ml/minute. 
overall yields were approximately 5 mgs of mutant protein. 
Assays 
Protein concentrations were determined by absorbance at 
281 nm using the conversion factor, 29,400 M-lcm-1 (2). Ac-
tivity assays were done at 30°C in O.l M potassium phosphate, 
pH 7, using a Beckman DU-7 spectrophotometer with l cm path 
length cells for assays of activity on benzylpenicillin or 
ampicillin. For assays of activity on cephalothin an optical 
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quartz block was inserted into the cuvet to reduce the path 
length to 1 mm. Hydrolytic cleavage of cephalothin was 
followed at 265 nm, at 240 nm for benzylpenicillin and at 235 
nm for ampicillin. The ~( values for cephalothin, benzylpen-
icillin and ampicillin were 7900, 500, and 825 M-lcm-1, re-
spectively (20). 
Western blotting 
Aliquots of 20~L of selected fractions from the DE-52 
column were electrophoresed on a 15 cm 12% SDS-polyacrylamide 
gel with a 2 cm 3.5% stacking gel. Protein was transferred 
to nitrocellulose (Schleicher and Schuell, BA 85) using a 
Biorad Transblot cell with a 40 to 60 volt field for 5 to 7 
hours. B-lactamase was visualized using a staining system 
based on anti-B-lactamase antibody and a Vectastain staining 
kit (Vector Laboratories, Burlingame, CA) as described in 
Chapter 2. 
Reaction of Lys73-->Cys with ethylenimine 
Mutant protein (2.0 mL, 0.36 mg/mL, in 300 mM Tris, pH 
8.4, purified by FPLC) was made 4.5 M urea by addition of 
solid urea. An aliquot of 200 rL of freshly synthesized 
ethylenimine was added and the solution incubated at RT for 
35 minutes. Another 200fAL aliquot of ethylenimine and 0.06 
g urea were added and the solution incubated for 35 minutes. 
A 100 ~L aliquot of 3 M Tris pH 7 was added and the solution 
dialyzed against 3 L of 25 mM Tris, pH 7. The solution was 
then dialyzed against 25 mM TEAC, pH 7.25, before FPLC 
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purification using the conditions described in the purifi-
cation section. 
Ethylenimine reaction conditions 
Mutant Lys73-->Cys (0.17 mg/ml, in 0.5 M sodium phos-
phate, pH 8.4) was divided into six 400 µL aliquots. The 
conditions listed in Table 1 were used for the derivatization 
reaction. Three 40 µL additions of ethylenimine were made 
separated by 40 minute reaction times. After the reaction 
the samples were dialyzed against 25 mM Tris, pH 7, using 
Spectrapor lOK MW cutoff dialysis tubing. Samples were 
assayed for protein concentration and B-lactamase activity. 
Attempt to observe catalytic burst 
The mutant Lys73-->Arg at protein concentrations of 0.6, 
0.9 and 1.8 mg/ml in 25 mM Tris, pH 7 was incubated in a 
cuvet at 30°C containing an optical quartz block for 10 
minutes. The solution was made 2 mM in cephalothin and the 
change in absorbance followed at 260 nm. After 40 to 60 
minutes of reaction a 30 ~L aliquot was removed and assayed 
for activity on benzylpenicillin using standard assay 
conditions. 
Search for active revertants 
~ coli LSl harboring plasmids pBR322K73R and pBR322K73C 
were grown to saturation at 37°C in L broth containing 15 
mg/L tetracycline. An aliquot (100 µL) was plated onto an L 
agar plate containing 15 mg/L ampicillin and incubated at 
37•c. serial dilutions of cells from the tetracycline 
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culture were made and plated onto L agar plates containing 15 
mg/L tetracycline to quantitate the number of cells plated. 
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Results 
The purification of presumably inactive mutants of B-
lactamase is greatly simplified by the use of a strong in-
ducible promoter such as the tac promoter. The tac promoter 
is a fusion of the lac and trp promoters and, when used in a 
strain that constitutively expresses the lac repressor, ef-
fectively shuts off expression of B-lactamase until the ad-
dition of IPTG (21). Therefore, the tac promoter may be 
useful for the expression of lethal proteins. The induction 
was carried out at 37°C for from 20 to 75 minutes since the 
thermal and proteolytic stability of mutants of B-lactamase 
at Lys73 in vivo as determined by western blotting was shown 
to be comparable to the stability of the wild-type enzyme. 
The overproduction of B-lactamase following the addition of 
IPTG allows the easy identification of its position in column 
fractions during the purification procedure. The osmotic 
extrusion and ammonium sulfate precipitation were carried out 
without the benefit of an assay, on the assumption that the 
mutants would behave similarly to the wild-type enzyme. 
After chromatography on OE-52 cellulose the position of the 
mutant B-lactamase was determined by either western blotting, 
by mobility on SOS-PAGE gels, or, after discovery of low 
levels of activity on benzylpenicillin, by activity assay 
(Figure 3). Identification of B-lactamase bands on SOS-PAGE 
gels is facilitated by the unusual orange-brown color of the 
B-lactamase band on staining by silver (22), when most pro-
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teins stain gray to black. Subsequent gel filtration chro-
matography gave apparently homogeneous protein. 
Purification of B-lactamase by FPLC represents a major 
simplification and improvement over the use of the gel f il-
tration column. The presence of a small amount of an un-
identified contaminating protein that runs on SOS-PAGE gels 
at about the same molecular weight as B-lactamase was removed 
by FPLC purification. The use of the DE-52 column prior to 
FPLC chromatography will ensure removal of contaminating pro-
teins that might bind irreversibly to the FPLC column. Rep-
resentative FPLC chromatograms are shown in Figure 9 for the 
wild-type and Lys73-->Cys mutant using the conditions des-
cribed in the Materials and Methods section. 
Purified mutants Lys73-->Cys and Lys73-->Arg maintain 
low levels of activity on benzylpenicillin. The values for 
kcat and KM shown in Table 1 were obtained from Lineweaver-
Burk plots generated from single reaction progress curves 
using [SJ, the average substrate concentration, and v, the 
average reaction velocity, over a region of the curve, ac-
cording to published procedures (23). The value of kcat/KM 
on benzylpenicillin for Lys73-->Cys was .012% of the value 
for wild-type enzyme and the value of kcat/KM for the Lys73 
-->Arg mutant was 0.015%. The value of kcat/KM for the 
Lys73-->Arg mutant on cephalothin is .007 % that of the wild-
type enzyme. The upper limit of activity for the Lys73-->Cys 
mutant on cephalothin is approximately 0.001 sec-1 . 
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* The values for/1/1GT, the difference between the binding 
energies of the transition states of the mutant and wild-type 
enzymes can be calculated from the following equation, 
.. 
/1/1GT = -RTln[ (kcatfKM)Af (kcatfK)a]. 
The increase in the binding energy of the transition state of 
the mutants is 5.4 kcal/mole compared to the value of the 
wild-type enzyme on benzylpenicillin, and is 5.5 kcal/mole 
for the Lys73-->Arg mutant on cephalothin. The activation 
' t energy, llGtr, is the sum of two components, /1 G , the acti-
vation energy of bond making and bond breaking, andllGs, the 
substrate binding energy. The Michaelis constant, KM, is a 
function of l1Gs· Since the values of KM of the mutants on 
benzylpenicillin are comparable to the value for the wild-
type enzyme, /1 Gs has not changed. Therefore the increase in 
* • ll/1GT is due to an increase in l1G , the activation energy in-
volved in carrying out the chemical conversion of bound sub-
strate to the transition state. 
The activity associated with the mutants is due to the 
mutants and not to a small amount of contaminating enzyme of 
much higher specific activity. The activity cannot be due to 
a reversion to the wild-type codon at Lys73 since that would 
require a double mutation, which occurs less than 1 in 1012 
loci. No phenotypically active revertants were found on 
plating 108 cells of ~ coli harboring either plasmid 
pBR322K73C or pBR322K73R. The specific activity of four dif-
ferent preparations of the Lys73-->Cys mutant were within 20% 
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of each other, making an active reversion unlikely. Activity 
coelutes with the Lys73-->Cys mutant on the FPLC under con-
ditions where proteins differing by only a single charge can 
be separated. 
The variation of the rate of catalysis of the Lys73--> 
Cys mutant with increasing pH and with increasing temperature 
were determined and the results are shown in Figures 5 and 6, 
respectively. In an interesting contrast to the behavior of 
the wild-type enzyme which shows maximal activity at pH 6.5 
and a decrease in activity at higher pH, the Lys73-->Cys 
mutant is most active at pH 8.3 and loses activity sharply 
below pH 8. Both the wild-type enzyme and the Lys73-->Cys 
mutant show an increase in activity with increasing tempera-
ture. However, the increase for the mutant is much greater 
than the increase for the wild-type enzyme. The pH of the 
assay buffer increased by .05 pH units on heating from 30 to 
45°C, so the values for enzymatic activity of the mutant have 
been corrected for the increase that would result from in-
creasing the pH. 
The specific activity of the Lys73-->Cys mutant is 
greatly increased on treatment with ethylenimine. Initial 
efforts at converting Cys73 to aminoethy1Cys73 resulted in a 
mixture of partially derivatized protein with specific 
activities of about 20 sec-1, compared to 0.25 sec-1 for the 
unreacted mutant. Isoelectric focussing gels of the reaction 
mixture showed most of the protein remained underivatized. 
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Since ethylenimine is known to be a highly reactive reagent 
(24,25) the most likely explanation of low yields of conver-
sion was thought to be steric hindrance of the cysteine side 
chain at position 73. To increase the percentage of deriva-
tization the reaction conditions were varied to unfold the 
native protein structure and expose the sulfhydryl to reac-
tion, as described in Table 2. The highest specific activity 
was obtained with 4 M urea in the reaction mixture suggesting 
the Cys73 side chain is buried in the native protein and ex-
posed in the partially denatured protein at pH 8.4. While 
the wild-type enzyme regains activity after exposure to 4 M 
urea at pH 7.0 when diluted into the assay buffer (10), under 
the conditions employed in this work at pH 8.4, a 50% irre-
versible activity loss was observed with the wild-type con-
trol reaction which may be due to the combination of the ef-
fects of high pH and urea. This activity loss of the wild-
type enzyme was not dependent on the presence of ethylen-
imine. Higher protein concentrations, such as 0.6 mg/ml, 
than those described in Table 2 were found to increase the 
specific activity of the reaction mixture. However protein 
precipitated from the reaction solution during the dialysis. 
These observations are probably due to a cooperative effect 
of protein concentration on unfolding, because of favorable 
intermolecular associations when hydrophobic regions become 
exposed. The precipitated protein is probably in the form of 
aggregates of B-lactamase. Therefore, an intermediate pro-
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tein concentration of 0.3 mg/ml was chosen for the reaction. 
An FPLC chromatogram of the reaction mixture is shown in 
Figure 8. Though the elution times of the native and deriva-
tized mutant vary slightly from native Cys73 and wild-type, 
respectively, the difference in elution times agree well (6.6 
vs 6.7 minutes). The kinetic parameters of the chemical re-
vertant were determined for benzylpenicillin and cephalothin 
and are shown in Table 1. The value for kcatlKM for the 
chemical revertant is 62% of that for the wild-type enzyme on 
benzylpenicillin, a 5000-fold increase over the value of the 
Cys73 mutant. Chromatography of urea-treated wild-type en-
enzyme that had been inactivated to 54% of its original spe-
cific activity on the FPLC caused a gain in specific activity 
to 69% of the original value. Therefore, chromatography on 
the FPLC probably removes some but not all of the denatured 
protein, and the value of the catalytic efficiency of the 
chemical revertant reflects a minimum value. 
To determine at what point in the catalytic mechanism 
the mutants are defective, the ability of the Lys73-->Arg 
mutant to give burst kinetics on cephalothin was observed. A 
small burst of less than 0.003 OD was observed independent of 
protein concentration. Bursts of this magnitude were ob-
served in the absence of mutant enzyme. Incubation of Lys73 
-->Arg with cephalothin followed by 50-fold dilution into 
assay buffer with benzylpenicillin showed linear kinetics 
with no evidence of a lag in the assay. If the acyl-enzyme 
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intermediate is thermodynamically stable relative to the 
enzyme-substrate complex and if deacylation is the rate-de-
termining step, then burst kinetics with cephalothin and a 
lag on dilution into a benzylpenicillin solution should have 
been observed. The acyl-enzyme intermediate is stable rel-
ative to the ES complex since the rate of B-lactam ring 
closure has been measured to be one third the rate of ring 
opening (30). Therefore, the absence of a burst with ceph-
alothin or a lag on dilution of cephalothin-treated enzyme 
into a solution of benzylpenicillin indicates that acylation 
is probably still the rate-determining step and therefore is 
the step affected by the mutation. 
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Discussion 
None of the nineteen mutants resulting from amino acid 
substitutions at Lys73 of RTEM-1 B-lactamase is able to con-
fer a resistant phenotype to ~ coli LSl cells to low levels 
of ampicillin. As discussed in Chapter 3, the lack of pheno-
typic resistance could be the result of one or more of sev-
eral factors, including problems with transcription, trans-
lation, translocation, stability to thermal denaturation or 
to proteolysis, or intrinsic enzymatic activity. The results 
of the western blots of Chapter 3, which showed that all 
nineteen mutants were present in amounts in vivo comparable 
to the amount of the wild-type enzyme rule out all possibil-
ities except the intrinsic enzymatic activity. The mutants 
Lys73-->Cys and Lys73-->Arg were purified to prove that the 
intrinsic enzymatic activity of the mutants is lowered rela-
tive to that of the wild-type enzyme and to attempt to define 
the molecular basis for the defect in activity. Lys73-->Arg 
was chosen because it is the most conservative change of 
amino acid from lysine and Lys73-->Cys was chosen because of 
the chemical versatility of the sulfhydryl. 
The purification of presumably inactive mutants of B-
lactamase is made possible by the use of the tac promoter. A 
fusion of the lac and trp operons, the tac promoter, when in-
duced, can convert as much as 30% of the total cellular pro-
tein to the induced protein, allowing the easy identifi-
cation of the protein by mobility on SOS-PAGE gels of total 
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cellular extracts (21). In the case of B-lactamase, the lo-
cation of the protein in the periplasmic space makes for easy 
fractionation of cellular proteins by osmotic extrusion which 
both eliminates cytosolic proteins and, since it releases 
mutant B-lactamase into the extrudate, proves the processing 
and secretion of the mutants are not significantly affected. 
The identification of the location of the mutant B-lactamases 
among the fractions off the column was confirmed by western 
blots and by low levels of B-lactamase activity. 
Despite the lack of a resistant phenotype to ampicillin 
in cells containing mutants, the purified mutants maintain a 
low level of activity on benzylpenicillin. The ratio of 
kcatfKM for both mutants to kcatfKM for the wild-type is 
lxlo-4 inferring an increase of 5.4 kcal/mole of activation 
energy. The Lys73-->Arg mutant maintains kcat on cephalothin 
at 3% of its activity on benzylpenicillin, and the ratio of 
kcat on cephalothin to that on benzylpenicillin for the wild-
type enzyme is 6%. The upper limit for activity of the 
Lys73-->Cys mutant is estimated as 0.5% of its activity on 
benzylpenicillin. Since the wild-type enzyme and Lys73-->Arg 
mutant have appreciable activity on cephalothin and the Lys73 
-->Cys mutant does not, these results indicate the positive 
charge of the side chains of Lys and Arg may assist in the 
catalysis of cephems. They also point out the more stringent 
requirements for hydrolysis of cephems, as evidenced by the 
finding that mutations at Thr71 also have a greater reduction 
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of catalytic efficiency on cephems compared to that on penams 
(10). The decrease of four orders of magnitude in catalytic 
efficiency for the mutants relative to the wild-type enzyme 
on benzylpenicillin does not mean the mutants are not en-
zymes. The background rate for the hydrolysis of penams and 
cephems has been measured as 0.2 M-lsec-1 so the mutants 
cause a sx104 increase in reaction rate (26). The value of 
KM for both mutants on benzylpenicillin is not significantly 
different from the value for the wild-type enzyme. If one 
assumes that KM reflects the intrinsic binding constant for 
substrate and enzyme, the binding is not significantly af-
fected in the mutants. Therefore the main effect of the 
mutations is on kcatr the catalytic rate. 
The reactivation or chemical reversion of the Lys73--> 
Cys mutant was accomplished by reaction with ethylenimine. 
The addition of the E-amino group to the amino acid at pos-
ition 73 restores 62% of the catalytic efficiency on benzyl-
penicillin of the wild-type enzyme. This demonstrates both 
that the mutants are capable of efficient catalysis and that 
the only functionality they are missing is the amino group at 
position 73. The efficient conversion of the Cys73 mutant to 
aminoethy1Cys73 could only be accomplished under conditions 
where the protein was at least partially unfolded, indicating 
in the native state the side chain of Cys73 is buried in the 
protein or is sterically or electrostatically hindered to 
reaction with small molecules. By contrast, the side chain 
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of Lys73 is probably exposed to solvent in the native state 
since the wild-type enzyme can be separated from Cys73 by 
FPLC and the reaction of a Class A B-lactamase from ~ aureus 
PCl with methyl acetimidate under nondenaturing conditions 
leads to inactivation presumably by reaction with an essen-
tial amino group (31). The reaction with ethylenimine was 
carried out at pH 8.4 since the sulfhydryl of Cys73 is nega-
tively charged at that pH which will tend to increase both 
its exposure and nucleophilicity. Appreciable activity on 
cephalothin is gained by reaction of Cys73 with ethylen-
imine. The value of kcatlKM for the aminoethy1Cys73 on ceph-
alothin is 9% that of the wild-type enzyme. 
The molecular basis for the drastic reduction in the 
catalytic efficiency of the mutants relative to that of the 
wild-type enzyme could be the result of several factors. The 
amino group of the lysine side chain may participate in a 
hydrogen bond with the active site serine hydroxyl to in-
crease the nucleophilicity of the hydroxyl. However, at pH 7 
the €-amino group of the lysine is most likely positively 
charged, making this possibility unlikely. Also, by the 
usual criterion of reaction with diisopropyl fluorophosphate 
the serine hydroxyl is not activated (27). Evidence exists 
that a conformational change occurs in the RTEM enzymes on 
binding substrate (28). The lysine side chain may be in-
volved in mediating the conformational change which could be 
important in catalysis. The amino group may be important in 
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maintaining the correct tertiary conformation of the enzyme 
for efficient catalysis in a way that is not reflected by its 
in vivo stability to proteases. However, the value of KM is 
not significantly changed from that of the wild-type enzyme, 
as might be expected if a conformational change had oc-
curred. The amino group of the Lys73 side chain may inter-
act directly with the bound substrate molecule, by an ion 
pair interaction with the carboxylate group of the thiazine 
or thiazolidine ring of cephems or penams, respectively. 
This interaction may serve to orient the substrate for effi-
cient acylation. The interaction between the amino group and 
the carboxylate could serve to produce a torque on the B-lac-
tam ring, increasing the rate of hydrolysis. The E-amino 
group of the lysine may act to polarize the lactam carbonyl 
making acylation more rapid. The rate of deacylation for 
D-alanine carboxypeptidase IA of ~ coli was decreased on 
reaction of the enzyme with sulfhydryl reagents while the 
rate of acylation was not affected (29). The finding that 
the Lys73-->Cys mutant has its maximal turnover rate at pH 
8.3, the pKa of the sulfhydryl of cysteine, indicates a nuc-
leophilic anion at position 73 increases the activity of the 
mutant and may be involved in deacylation in a similar 
fashion. The E-amino group may donate a proton either to the 
amide nitrogen after the lactam bond is broken or to the 
active site serine after deacylation. 
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Figure 1 
A) Secondary structural elements of B-lactamase from 
~ licheniformis -749/c (left) and D,D-carboxypeptidase 
from Streptomyces R61 (right). Taken from reference 13. 
B) The alpha carbon atoms 25-42 of the active site polypep-
tide with a bound cephalosporin of the D,D-carboxypep-
tidase from Streptomyces R61. Taken from reference 12. 







A) Partial restriction map of plasmid pJN 
B) Agarose gel electrophoresis of restriction fragments 
generated by digestion by AvaI restriction endonuclease 
of plasmid pJN containing no mutation (lane 1), the Lys73 
-->Arg mutation (lanes 2 and 3), the Lys73-->Cys mutation 
(lanes 4 and 5), the Lys73-->His mutation (lanes 6 and 7), 
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Figure 4 
Ultragel ACA 54 column profile of the 
purification of Lys73-->Cys 
































The variation of turnover rate of Lys73-->Cys and 




















The variation in turnover rate with temperature 
for Lys73-->Cys and wild-type enzyme 
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A) FPLC elution trace of wild-type B-lactamase 
B) FPLC elution trace of Lys73-->Cys 





FPLC separation of the ethylenimine and Lys73-->Cys reaction 
mixture. Upper trace- activity of collected fractions(! min. 
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Conditions of reaction with ethylenimine 
before reaction 
0.5 M sodium phosphate, pH 8.4 
0.5 M sodium phosphate, pH 8.4 
condition 2 + 1 mM PenG 
condition 2, 37°C 
condition 2, 4 M urea 
condition 2, 37•c, 4 M urea, 
1 mM PenG 













Half-lives of Activity for Lys73-->Cys and wild-type 
as a Function of pH 
t 112 (min) 












*Indicates greater than 90% of the original activity was 
retained during this time period. 
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Appendix 
The Reaction of Sulfhydryl Reagents with Diol 
Dehydratase, a Coenzyme B12-Dependent Enzyme 
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148 
Abstract. The reaction of diol dehydratase with several 
sulfhydryl reagents has been investigated. Apoenzyme was 
inactivated by phenylmercuric, methylmercuric, and mercuric 
chloride and iodoacetate. Holoenzyme was protected against 
inactivation by phenylmercuric ion and iodoacetate but not 
against methylmercuric or mercuric ion. Radioactive methyl-
mercuric ion labeled only the 60 kdalton subunit, 1 equiv-
alent per subunit. The presence of cyanocobalamin reduced 
the labeling of the 60 kdalton subunit by iodoacetate from 2 
equivalent per enzyme molecule to 1 equivalent per enzyme 
molecule. The binding of coenzyme was prevented by reaction 
of apoenzyme with phenylmercuric ion. Coenzyme was released 
from holoenzyme by reaction with methlymercuric ion. These 
results are consistent with the hypothesis (Kunc, s., Toraya, 
T., and Fukui, S. (1981) Arch. Biochem. Biophys. 210, 474-
480) that diol dehydratase contains two classes of free 
sulfhydryls: one essential for enzymatic activity and asso-
ciated with coenzyme binding and another nonessential for 
activity and not protected by coenzyme analogs from reaction 
sulfhydryl reagents. These two free sulfhydryls reside on 
the 60 kdalton subunit. 
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Introduction 
The structure of vitamin B12 1 the substance responsible 
for the abatement of pernicious anemia, was solved in 1955 by 
x-ray crystallography by Hodgkin and coworkers (1). Their 
solution capped a monumental effort begun by Minot and Murphy 
in 1926 directed towards discovering the cause of this fatal 
disease (2). The vitamin has at its center a cobalt(III) 
atom ligated to the four central nitrogens of a corrin ring. 
The D ring of the corrin has as part of one of its side-
chains a dimethylbenzimidazole which, in turn, ligates to the 
cobalt in the ~ position. A cyanide molecule occupies the 
remaining coordination site, the B position. A biologically 
active form of the vitamin is adenosylcobalamin, where the 
cyano ligand, an artifact of the purification, is replaced by 
5'-deoxyadenosine, one of the few naturally occurring biolog-
ical compounds with a carbon-cobalt bond. (Figure 1) 
Cobalamin is synthesized exclusively by microorganisms. 
These bacteria contain adenosylcobalamin-dependent enzymes 
analogous to the mammalian enzymes which participate in the 
metabolism of fatty acids (3,4) and directly or indirectly in 
the biosynthesis of deoxyribonucleotides and some amino acids 
(5). Since bacterial enzymes are generally easier to obtain 
than mammalian, the bacterial adenosylcobalamin-dependent 
enzymes have been the more thoroughly studied. There are ten 
different adenosylcobalamin-dependent enzymes which catalyze 
the exchange of a hydrogen atom for an adjacent group "X", 
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where "X" may be alkyl, acyl, OH, or NH2 , reactions that have 
essentially no counterpart in organometallic chemistry. 
Propanediol dehydratase [(RS)-1,2-propanediol hydrolyase, EC 
4.2.1.28], one of the ten enzymes, catalyzes the rearrange-
ment of 1,2-propanediol to 1,1-propanediol followed by stere-
oselective dehydration to propionaldehyde (6). An adenosyl-
cobalamin-dependent enzyme, not fitting the above reaction 
scheme, is ribonucleotide reductase, which catalyzes a reduc-
tion (7, 8) • 
The currently accepted mechanism for hydrogen transfer 
is outlined in Figure 2. Substrate binding is thought to 
cause a homolytic cleavage of the 5'-carbon-cobalt bond, 
giving a 5'-adenosyl radical and a Co(II) species. The or-
ganic radical abstracts the pro-R hydrogen from C-1 of (R)-
1,2 propanediol or the pro-S hydrogen from (S)-1,2 propane-
diol (9) giving a substrate radical 5'-deoxyadenosine, and 
Co(II). The hydroxyl of C-2 is transferred to C-1 in an 
unknown fashion, giving a "product" radical. This radical 
abstracts a hydrogen from the 5 1 position of the deoxyaden-
osine, completing hydrogen transfer. 
The role of the protein in the conversion of 1,2-pro-
panediol to propionaldehyde is much less understood. Im-
provements in the purification procedure of diol dehydra-
tase have recently been reported (10). The previous method 
(11) gave an enzyme of molecular weight 230 kdaltons, which 
could be dissociated in the absence of substrate into two 
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components, F and S, with molecular weights of 26 and 200 
kdaltons, respectively. Component F was composed of a single 
subunit while component S dissociated into four types of 
subunit with molecular weights 60, 23, 15.5 and 14 kdaltons. 
Both components were necessary for full activity. The 
improved method recognizes that diol dehydratase is associ-
ated with the bacterial membrane and is susceptible to prote-
olysis by endogenous proteases. The improved isolation 
procedure yields an enzyme of higher specific activity in 
greater quantity than the previous method. The diol dehydra-
tase thus isolated has a molecular weight of 260 kdaltons and 
is composed of seven subunits; two 60, one 51, two 29, and 
two 15 kdalton subunits (12). 
Sulfhydryl reagents inactivate diol dehydratase. A 
highly specific reagent for sulfhydryls, p-chloromercuribenz-
oate (pCMB), inhibits enzymatic activity if added to apo-
enzyme but has little effect on the holoenzyme, or to enzyme 
which has bound methylcobalamin or cyanocobalamin {13); 
however hydroxycobalamin does not protect the enzyme from 
inactivation by organic mercurials. Iodoacetate and N-ethyl-
maleimide also inactivate proteolyzed apoenzyme obtained by 
the method of Poznanskaja et, al. (14). After reaction with 
iodoacetate, component S could not reform active enzyme with 
component F (15). Further, the proteolyzed form of diol 
dehydratase was shown to contain two reactive sulfhydryl 
groups per enzyme molecule by reaction with pCMB {16). One 
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of the sulfhydryls was essential for activity and was 
protected from reaction by the presence of cyanocobalamin, a 
competitive inhibitor of coenzyme binding. The other sulfhy-
dryl was nonessential and was not protected by the bound 
vitamin. Conversely, when apoenzyme was reacted with either 
pCMB or dithiobis-2-nitrobenzoic acid (DTNB) it completely 
lost the ability to bind cyanocobalamin, but not when it was 
reacted with N-ethylmaleimide. The pCMB-treated enzyme did 
not dissociate into subunits. The authors concluded the es-
sential sulfhydryl was located at or near the coenzyme 
binding site of diol dehydratase. 
To help resolve the differences between diol dehydratase 
isolated by the method of Poznanskaja, et al. (11), and diol 
dehydratase isolated by the method of McGee and Richards 
(10), and to gain information about the coenzyme-binding site 
on the enzyme, we undertook studies on the reactivity of diol 
dehydratase, purified according to McGee and Richards (10), 
towards several sulfhydryl reagents. The change in activity 
of apo- and holoenzyme in the presence of different organic 
mercurial reagents was observed. Radioactive methylmercuric 
chloride was used to show that there are two reactive 
sulfhydryls per enzyme molecule, both associated with the 
60Kdalton subunits. On binding cyanocobalamin the number of 
sulfhydryls available to react with iodoacetate is decreased 
from two to one. Apoenzyme, after reaction with methyl-
mercuric chloride is unable to bind coenzyme. Coenzyme is 
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released from holoenzyme in the presence of methylmercuric 
chloride. These results indicate that at least one of the 
two free sulfhydryls of the two 60Kdalton subunits is impor-
tant, either directly or indirectly for coenzyme binding. 
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Materials and Methods 
203HgCH2Cl was purchased from New England Nuclear, 
Boston, Massachusetts. The specific activity was originally 
0.8 mCi/mg. Calculations of subsequent experiments assumed a 
half-life of 46.6 days. 
l-[14~]-ICH2COOH (11.1 mCi/mmole) and 2-[3H]-ICH2COOH 
(193 mCi/mmole) were from New England Nuclear. 
IdHJ-Coenzyme B12- was synthesized according to McGee 
(1982). 
Diol dehydratase was isolated by the method of McGee and 
Richards (1981). 
Inactivation of diol dehydratase by organic mercurials-
Diol dehydratase (7 units, 16 units/mL) was incubated with 
either 5 L of a 1 mg/mL solution of coenzyme or with 5 ~L of 
of .01 M K2HP04 , pH 8, at 37°C. Ten ~L of a 7.8 x lo-3 M 
solution of either CH3HgCl, phenylmercuric chloride, or 
mercuric chloride were then added and 5 ~L aliquots were 
removed over a period of hours and assayed. 
Reactivation of diol dehydratase inactivated by organic 
mercurials- Diol dehydratase (3 units, lOunits/mL) was 
inactivated as before. Reaction was allowed to proceed for 
from 4 minutes to three hours after which 10 ~L B-mercapto 
ethanol was added to quench the inactivation and effect 
reactivation. Aliquots of 5 f L were removed and assayed both 
before and after addition of the B-mercaptoethanol. The 
experiments were repeated in the presence of 20 fmoles of 
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coenzyme for methylmercuric chloride and mercuric chloride. 
Activity assay- The method used was that of Bachovchin, 
et al. (18), employing yeast alcohol dehydrogenase (Sigma) 
and NADH (Sigma) to reduce product propionaldehyde to 1-
propanol. The production of propionaldehyde was measured by 
following the decrease in absorbance of the solution at 340 
nm, due to oxidation of NADH to NAO+ in an excess of alcohol 
dehydrogenase activity. Sample volumes were 2.0 mL and 
reaction was initiated by the addition of either coenzyme or 
holoenzyme in the dark at 37°C. One unit of activity is 
defined as that amount of enzyme activity that will catalyze 
the conversion of one micromole of substrate to product per 
minute at saturating substrate concentrations at 37°C. 
Coenzyme binding experiments- Dial dehydratase (100 
units) was dialyzed against 2 mM dl-butanediol, .01 M KH2Po4 , 
pH a. One mL (10 units) was incubated with lOO~L 2 mM dl-
butanediol, .01 M KH2Po4 , pH 8 or with 100 ~L 1.73 x lo-3 M 
phenylmercuric chloride, .01 M KH2Po4 , pH a, for 20 minutes. 
[3H]-coenzyme B12 (50 fL of a 1.94 x lo-5 M solution, 5.9 
dpm/ mole) was added in the dark and allowed to bind 20 
minutes. The solution was applied to a 2.5 x 13 cm Biegel P-
4 column and eluted with 2 mM dl - butanediol, .01 M KH2P04, pH 
a, in the dark. Fractions (2.1 mL) were collected and 1 mL 
was counted with 10 mL Aquasol II. 
Dial dehydratase (1 mL, 10 units) in 2 mM dl-butanediol 
.01 M KH2Po4 , pH a, was incubated with 50 fL of [
3H]-coen-
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zyme (1.94 x lo-5 M) for 20 minutes. Then, 100 ~L of a 1.7 x 
10-3 M methylmercuric chloride, .01 M KH2Po4 , pH 8, solution 
was added. The solution was incubated for 20 minutes and 
then applied to the Biegel P-4 column. Fractions were 
collected and counted as before. 
Labeling of the free sulfhydryls of diol dehydratase by 
203HgCl- oiol dehydratase (10 units, 22 units/mL) was 
incubated at room temperature with stirring for ten min-
utes with or without coenzyme. Methylmercuric choride (.14 
,.uncle, lOl"'Ci) was added and the mixture stirred for from 30 
minutes to three hours. The solution was then dialyzed 
against two changes of three Leach .01 M K2HP04 , pH 8, for 
several hours. The protein sample was precipitated by the 
addition of three volumes of spectrograde acetone (Baker 
Analytical) and was centrifuged in a Sorvall GLC-2 centri-
fuge at 3000 rpm. The protein was denatured by heating in 1% 
SOS and the subunits separated by SOS-PAGE (10% acryl-
amide). The gel was stained with Coomassie Brilliant Blue, 
destained and the protein bands were sliced out with a razor 
blade. The slices were counted for gamma radiation in a 
Beckmann Gamma 4000 counter, on the 5lcr channel. Counting 
efficiency was determined to be 65% by counting a sample of 
stock methylmercuric chloride. The effect of the presence of 
coenzyme on the labeling was investigated by carrying out the 
same procedure as before except that prior to the addition of 
the HgCH3Cl, 5 µL of a 1 mg/mL solution of coenzyme were 
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added to the enzyme and the solution stirred for 20 minutes 
at room temperature in the dark. Propanediol {l M) was 
present in all cases. 
Differential labeling experiments-Diel dehydratase {0.5 
mL, 25 units/mL) was incubated with or without cyanocobal-
amin {l mg/mL) for 10 minutes at room temperature. [14c]-
Iodoacetate {10 to 50 pL of a solution made 1 M by the 
addition of an appropriate amount of cold iodoacetic acid) 
was added and the solution incubated in the dark for 20 
hours. The mixture was diluted to 10 mL in Buffer G in an 
Amicon Diaflo apparatus fitted with a PM-30 membrane and an 
aliquot of [3H]-iodoacetate-labeled diol dehydratase added as 
a tracer. The solution was dialyzed by continuous flow 
against 80 mL of Buffer G {10% glycerol, 5% propanediol, .01 
M sodium phosphate, pH 8) and then concentrated to 1 mL. 
Three volumes of acetone were added and the protein precip-
itated by centrifugation at 7000 rpm for 15 minutes. SDS-
PAGE sample buffer {50 µL) was added and the sample was run 
on a 10% acrylamide gel. The gel was stained with Coomassie 
Brilliant Blue, destained and sliced into 2 mm slices with a 
razor blade, noting which slices contained the 60 Kdalton 
subunit. The gel slices were placed in glass scintillation 
vials to which 1 mL of 30% H202 was added. The capped vials 
were incubated at 60°C overnight. Aquasol {10 mL) was added 
and the samples were counted for radioactivity in a Beckmann 
LS 9000 scintillation counter. 
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Results 
The results of the inactivation experiments are shown in 
Figure 3 for reaction with methylmercuric and phenylmer-
curic ion, and in Figure 4 for mercuric ion. It is apparent 
that phenylmercuric ion inactivates apoenzyme, but in the 
presence of coenzyme the inactivation is substantially re-
duced. However, the presence of coenzyme has no discernable 
effect on inactivation by either mercuric ion or methylmer-
curic ion. The rate of inactivation by mercuric ion was much 
slower than that of methyl- or phenylmercuric ion, an effect 
that may be explained by the tighter binding of hydroxyl ion 
to mercuric ion than to methylmercuric ion. The pK of 
dissociation of Hg(OH) 2 is 11.3, while that of CH3Hg(OH) is 
9.5 (19). A difference in pK of 1.8 means at an initially 
equivalent concentration of HgC1 2 and CH3HgCl there will be 
approximately 75 times as much free methylmeruric ion as 
hydroxymercuric ion. Since the rate of inactivation in this 
case is proportional the the amount of free label, the rate 
of inactivation by methylmercuric ion should be 75 times that 
of mercuric ion, as is observed. 
The reactivation of diol dehydratase previously inacti-
vated by organic mercurials could be accomplished in some 
cases, as is shown in Figure 5. The inactivation caused by 
phenylmercuric ion was almost fully reversible for periods of 
inactivation of at least one hour. Reaction of apoenzyme 
with methylmercuric ion caused an inactivation that was 
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irreversible after 15 minutes of inactivation, and only par-
tially reversible at 5 minutes of inactivation. The holo-
enzyme inactivated by methylmercuric ion could be 88% reac-
tivated after five minutes of inactivation but could not be 
reactivated after one hour of reaction with methylmercuric 
ion. Mercuric ion caused a slower inactivation than the 
organic mercurials and this inactivation could not be re-
versed after three hours of inactivation. 
Figure 6 shows the results of experiments investigating 
the binding of coenzyme to enzyme inactivated by phenyl-
mercuric chloride. Measurements of absorbance at 280 nm in-
dicate that holoenzyme and apoenzyme elute in the void vol-
ume and are completely separated from unbound coenzyme. No 
significant difference in the quantity of protein eluted from 
the column between runs was observed (data not shown). Under 
conditions when the enzyme was completely inactivated by 
phenylmercuric chloride, less than .1% of the radiolabeled 
coenzyme associated with the control (active) chromatogram 
eluted in the void volume, indicating the inactivated protein 
does not bind coenzyme. Holoenzyme inactivated by methyl-
mercuric ion retains 11% of the radiolabeled coenzyme as-
sociated with the control run, indicating the coenzyme is 
largely released from the holoenzyme. The radioactivity 
eluting in the void volume of the control reaction corres-
ponds to .25 equivalent. 
The results of a typical labeling experiment of sos-
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denatured diol dehydratase by [14c]-iodoacetic acid are shown 
in Figure 6. Both the 60 and 51 kd subunits contain substan-
tial amounts of label and are well separated by the SOS-PAGE 
gel system. The small amount of label associated with the 29 
and 15 kd subunits probably corresponds to labeling of his-
tidines and methionines (24). 
The results of the radioactive labeling of the enzyme by 
methylmercuric chloride are shown in Table 1, both with and 
without coenzyme. The 60 kd subunit was the only subunit 
containing more than one equivalent of label per enzyme mo-
lecule. None of the other subunits contained counts cor-
responding to more than 0.4 equivalents of label per subunit 
under the reaction conditions employed. Therefore, it was 
concluded that neither the 51, 29 or 15 kd subunit contained 
free sulfhydryl groups susceptible to labeling by methyl-
mercuric ion, under the reaction conditions employed. It is 
evident that the number of counts associated with the 15 kd 
subunit is, in general, half that associated with the 29 kd 
subunit, suggesting nonspecific labeling. To correct for 
this nonspecific, molecular weight dependent labeling in the 
other subunits a correction factor of counts per kd of the 29 
kd subunit was applied to the 51 and 60 subunits, as is shown 
in Table 1. The labeling of the 51 kd subunit was never more 
than .1 equivalent per subunit greater than this background. 
The results suggest one sulfhydryl per 60 kd subunit is free 
to react with methylmercuric ion. It is evident that the 
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presence of coenzyme does not significantly alter the amount 
of labeling of any of the subunits. 
The effects of the presence of cyanocobalamin on the 
reactivity of the sulfhydryls of the 60 kd subunit towards 
iodoacetate were investigated. Increasing the concentration 
of label beyond 30 ~L added (60 mM) did not substantially 
increase the extent of labeling indicating the enzyme is ap-
proaching quantitative labeling under these conditions. 
Under saturating concentrations of cyanocobalamin the 60 kd 
subunit contains approximately half the amount of label 
present in the absence of cyanocobalamin when the enzyme is 
approaching quantitative labeling. Maximal labeling in the 
presence of cyanocobalamin was about one equivalent . label per 
enzyme and in the absence of cyanocobalamin was about two 
equivalents label per enzyme molecule. The addition of en-
zyme labeled by reaction with [3H]-iodoacetate as a tracer 
allows the calculation of quantitative yield of the 60 kd 
subunit during the dialysis, precipitation and electrophor-
esis after its labeling. 
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Discussion 
A new improved method for the isolation and purifica-
tion of diol dehydratase was recently developed (10) which 
yields more enzyme of higher specific activity than previous 
methods (3, 11). Previous methods gave yields of approxi-
mately 6% and a specific activity of about 60 units/mg, 
whereas the mew method gives yields of 40-50% and specific 
activity of 95 units/mg, making structural studies possible. 
The enzyme is composed of four different kinds of subunits 
with molecular weights of 60, 51, 29, and 15 kdaltons. They 
are present in a ratio of 2:1:2:2 (60:51:29:15) for an over-
all molecular weight of 260,000 daltons (12). Amino acid 
analyses show there are eight cysteine residues present per 
enzyme molecule, three in each of the 60 kd subunits and two 
in the 51 kd subunit, and none in either the 29 or 15 kd 
subunits. Sequence data for 40-45 of the N-terminal resi-
dues of each subunit have been obtained, but no cysteines 
have been located. No interchain disulfide bonds exist since 
the addition of OTT does not effect the migration of the 
subunits on SOS-PAGE (20). 
Organic mercurials are generally the reagent of choice 
for investigations of free sulfhydryl groups on proteins. A 
monofunctional organic mercurial, such as methylmercuric 
chloride, for the quantitation of free sulfhydryls prevents 
possible complications due to formation of intermolecular 
dimers on reaction of mercuric ion with proteins (21, 22). 
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Although nonspecific reactions have been reported (23) for 
organic mercurials, they tend to be much more specific than 
other sulfhydryl reagents (24). 
That each of the 60 kd subunits should contain at least 
one free sulfhydryl is easily envisioned in view of the amino 
acid data. Since there are no inter-chain disulfide bonds, 
the remaining two cysteines may either be joined by a di-
sulfide bond or they may be hindered to reaction either ster-
ically or by the ionic character of the local environment. 
Examples of both cases have been presented so neither may be 
ruled out (25, 26).· The small amount of labeling of the 51 
kd subunit, never more than .1 equivalent over background may 
be due to slight proteolysis of the 60 kd subunit giving rise 
to a fragment of approximately 51 kd molecular weight. This 
would mean the two cysteines of the 51 kd subunit are either 
joined in an intrachain disulfide or are not exposed to reac-
tion with water-soluble reagents. 
Amino acid analyses of the 29 and 15 kd subunits show no 
cysteines to be present. Radiolabeling data of these two 
subunits generally show some small amount of incorporation, 
never corresponding to more than .2 equivalent per subunit. 
The labeling of the 15 kd subunit was usually approximately 
half that of the 29 kd subunit. Nonspecific labeling by 
mercurials has been reported (23), generally occurring when 
the mercurial was used in excess, as was the case in these 
experiments. Both amide and carboxylate groups have been 
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implicated as the recipients of the reagent. Either of these 
two modes of labeling may be responsible since the number of 
carboxylate and amide containing side chains in each subunit 
is roughly proportional to the molecular weight {12). Gener-
ally this non-sulfhydryl binding is weak and the dialysis of 
the experimental procedure probably removes most of the 
spurious binding. Consequently twice the number of counts 
associated with the 29 kd subunit was subtracted from the 
counts of the 60 kd subunit to represent the methylmercuric 
ion binding to sulfhydryls. 
Experiments on the inactivation of diol dehydratase by 
mercurial reagents are consistent with the hypothesis that 
one of the two free sulfhydryls of the 60 kd subunit is 
essential for enzymic activity {16). All four sulfhydryl 
reagents tested {mercuric, methyl- and phenylmercuric, and 
iodoacetate) inactivate apoenzyme. Holoenzyme was protected 
against inactivation by phenylmercuric ion and iodoacetate. 
Iodoacetate is prevented from reaction with one of the two 
free sulfhydryls of the enzyme by the presence of cyanoco-
balamin, an analogue of the coenzyme. Presumably, the pro-
tected sulfhydryl is the essential one, although this could 
not be proven due to the long reaction times required for 
quantitative labeling and the faster inactivation of holoen-
zyme by oxygen and light. 
Holoenzyme is vulnerable to inactivation by mercuric ion 
and by methylmercuric ion. Uv-vis spectra of the coenzyme 
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alone was identical to that of coenzyme in the presence of 
either methylmercuric or mercuric ion, casting doubt on the 
possibility that inactivation occurs by reaction of the in-
activator with the coenzyme. Inactivation may occur by the 
inability of the coenzyme to protect the essential sulfhydryl 
or by reaction with the nonessential, unprotected sulfhydryl 
which causes a change in conformation that reduces or abo-
1 ishes activity. The different responses of the enzyme to 
these reagents compared to that with phenylmercuric ion and 
iodoacetate may be the result of differences in size, or 
hydrophobicity of the reagents. 
Experiments on the reactivation of diol dehydratase also 
show different results for these two classes of inactivator. 
Apoenzyme inactivated by phenylmercuric ion could be reactiv-
ated almost quantitatively by B-mercaptoethanol for periods 
of inactivation of at least one hour. Apoenzyme could not be 
reactivated after reaction with methylmercuric or mercuric 
ion. Holoenzyme could be partially reactivated after five 
minutes of inactivation by methylmercuric ion but not after 
one hour of inactivation. Binding of methylmercuric ion to 
either the unprotected (against phenylmercuric ion) sulfhy-
dryl or to the protected (against phenylmercuric ion) sulf-
hydryl causes a change in the enzyme, possibly of the con-
formation, that is irreversible. Reaction of phenylmercuric 
ion at either sulfhydryl does not produce this change since 
inactivation of apoenzyme is fully reversible. The presence 
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of coenzyme may delay this change slightly since holoenzyme 
could be reactivated partially after five minutes of inac-
tivation by methylmercuric ion. 
The loss of activity is accompanied by the loss of the 
ability of the enzyme to bind coenzyme. Apoenzyme inac-
tivated by phenylmercuric ion did not bind [3H]-coenzyme by a 
gel filtration assay. Holoenzyme inactivated by methylmer-
curic ion released the bound [3H]-coenzyme. Free sulfhyd-
ryls must be required, either directly or for the correct 
conformation of the enzyme, for the binding of the coenzyme. 
Another explanation may involve the enzyme's requirement 
for a monovalent cation for activity (13). Mercuric ion has 
an ionic radius of .66 A (27), which is too small to serve 
any role in retaining catalytic capability (28). It is not 
known whether divalent ions may bind in place of the monoval-
ent ion, but a divalent ion-enzyme complex would be inactive. 
This might be a possible mode of inactivation for mercuric 
ion. It is difficult to judge the effect of increasing the 
radius and changing the geometry of the ion by the introduc-
tion of phenyl and methyl groups. Since so little is known 
of the role and manner of action of the monovalent cation, 
little can be said of the importance of this possible mech-
anism of inactivation. 
The basis for the difference in reactivity of the two 
free sulfhydryls of the 60 kd subunits is unclear. The 
coenzyme itself is not symmetrical so that binding of the 
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coenzyme may create asymmetry between otherwise equivalent 
sulfhydryls. The sulfhydryls themselves may not belong to 
the same cysteines on each 60 kd subunit. It would be nec-
essary to isolate proteolytic fragments of sulfhydryl-
labeled 60 kd subunits for sequencing to determine if equi-
valent cysteines are labeled. There is one 51 kd subunit per 
enzyme which may introduce asymmetry to the enzyme molecule. 
These experiments do not rule out the possibilty that the 51 
kd subunit is also involved in the binding of the coenzyme. 
There remains the remote possibility that the 60 kd subunits 
are not identical for their entire sequences, although no 
discrepancies were noted from N-terminal sequences of the 
first 40 residues (12). 
Diol dehydratase isolated by previous methods (11) rep-
resents a proteolyzed form of the enzyme. The proteolyzed 
form could be resolved onto two components, F and s. Compo-
nent s could not reform active enzyme after reaction with 
iodoacetate, suggesting the essential sulfhydryl resides in 
Component S (16). Since the 60 kdalton subunit of diol de-
hydratase isolated by the improved method (10) contains both 
reactive sulfhydryls, this subunit is contained in Component 
s of diol dehydratase isolated by the earlier method. 
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Figure 1 
Adenosyl Cobalamin~ Dimethyl benzimidazole 
is the upper (~) ligand, and 5'-deoxyadenosine 












Postulated mechanism for hydrogen transfer. Ad denotes the 
adenosyl ligand; >Co< and >Co<, cobalt with and without the 
bond to carbon, respectively, in the corrin ring; SH ands·, 
the substrate and substrate radical, respectively; PH and 
P·, the product and product radical, respectively; ?, the 
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Fiqure 3 
Inactivation of apo- and holoenzyme in the presence of 
methyl- and phenylmercuric chloride. The percentage of 
original activity retained after reaction with organic 
mercurials is plotted for apoenzyme (0.6µM) with 
methylmercuric chloride(£, 0.26 mM) and phenylmercuric 
chloride (~, 0.26 mM) and for holoenzyme (0.6 fM) with 
methylmercuric chloride ( o, 0.26 mM) and phenylmercuric 
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Figure 4 
Inactivation of apo- and holoenzyme in the presence of 
mercuric chloride. The percentage of original activity 
retained after reaction with mercuric chloride (0.26 mM) for 





















I 2 3 
Reaction Time (HRS) 
179 
Figure s 
Reactivation of diol dehydratase inactivated by organic 
mercurials. Apoenzyme was inactivated as before (Figure 3) 
with phenylmercuric chloride (x), as was holoenzyme with 
methylmercuric chloride (6). After inactivation for from 5 
to 60 minutes, B-mercaptoethanol was added and allowed to 
react for 20 minutes after which the solution was assayed. 
The results are plotted for phenyl- (o) and methylmercuric 
chloride (D) . 
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Figure 6 
Coenzyme binding by mercurial-inactivated diol dehydratase. 
Results are shown for unreacted enzyme (o), for apo enzyme 
inactivated by phenylmercuric chloride (e), and for 
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[14c]-Iodoacetic acid labeling of denatured diol 
dehydratase. Subunits were separated by electro-
























Radiolabeling of the subunits of diol dehydratase 
by radioactive methylmercuric chloride. 
Reaction 
Time 60 kd 51 kd 29 kd 15 kd 
30 min.a Total counts 71437 20280 9112 4422 
Correctedb 53000 11168 
EquivalentsC .52 . 11 
30 min. Total counts 79768 8447 17060 9237 
Corrected 45708 
Equivalents .45 
30 min. Total counts 56790 6905 2121 1040 
Corrected 52548 2663 
Equivalents .52 .03 
2 hrs. Total counts 130137 28662 18471 8969 
Corrected 93200 10191 
Equivalents .91 . 1 
3 hrs. Total counts 195422 63253 52500 25420 
Corrected 90400 10753 
Equivalents .88 . 1 
a This determination was performed in the presence of co-
enzyme. The rest were performed in the absence of coen-
zyme. 
b The number of counts in the 29 kd subunit were subtracted 
from those of the 51 kd subunit and twice the number of 
counts in the 29 kd subunit were subtracted from those of 
the 60 kd subunit to correct for spurious labeling. 
c Calculations assume an enzyme specific activity of 95 
units/mg, an enzyme molecular weight of 260 kd, and a spe-
cific activity of the label of 0.4 Ci/mg. 
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Proposition 1 
structural and Kinetic Studies 
of DNA gyrase 
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Background 
DNA gyrase (bacterial topoisomerase II) catalyzes the 
introduction of negative supercoils into DNA coupled to the 
hydrolysis of ATP (reviewed in refs. 1-3). Gyrase was dis-
covered as the protein factor necessary for in vitro recom-
bination of relaxed DNA by ~ phage int protein on addition of 
ATP (4). Gyrase catalyzes supercoiling by causing a · site-
specific double strand break in a duplex DNA substrate, 
passing another duplex strand through the enzyme-bridged gap 
in the direction that decreases the linking number, and then 
resealing the break. The involvement of topoisomerases in 
several cellular processes has been implicated, including the 
initiation of replication (5), resolution of pairs of newly 
replicated DNA (6), transcription (7), and recombination (8). 
DNA gyrases from both ~ coli and Micrococcus luteus 
have been purified and the ~ luteus enzyme has been shown to 
have an A2B2 subunit structure as determined by chemical 
crosslinking studies (9). Hybrid proteins formed by mixing 
subunits from ~ coli and ~ luteus are fully active, indic-
ating the ~ coli enzyme has the same subunit composition 
(10). The genes for both subunits of the ~ coli gyrase have 
been cloned (11) and the sequence of gyrB has been published 
(12). The subunits are purified separately and activity is 
188 
reconstituted by addition of equimolar amounts of each sub-
unit (11). The A subunit is a homodimer in solution (13) and 
is the target of the antibiotics oxolinic and nalidixic acid 
(14) which act to trap an intermediate in which the enzyme is 
covalently attached to both 5'-ends of the double strand 
break via a phosphotyrosine bond (15). The B subunit is the 
target of the antibiotics novobiocin and coumermycin, which 
interfere with energy transduction by competitively preven-
ting the binding of ATP (16). Therefore, subunit A is in-
volved in strand breakage and subunit B in energy transduc-
tion. The molecular weights of the A and B subunits are 
about 105 and 95 kilodaltons, respectively, giving a mass of 
400 kilodaltons for the tetrameric complex (9). 
DNase I footprinting studies of the gyrase-DNA complex 
have shown the enzyme interacts with a region of about 140 
basepairs (bp) (18). The central 40 bp are resistant to 
cleavage by DNAase I centered about the gyrase cleavage 
site. The sequences flanking the central, protected region 
show enhanced cleavage by DNAase I every 10 to 11 base pairs 
with a 2-4 base pair stagger for sites on complementary 
strands (19-21), suggesting the 50 bp flanking sequences may 
be wrapped around the protein and exposed to digestion by 
DNAase I from only one side. Addition of ATP or a nonhydro-
lyzable ATP analog, B, oimido-ATP (ADPNP), had no effect on 
DNAase I cleavage patterns but did change cleavage patterns 
obtained by digestion with exonuclease III (21). Wrapping of 
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the DNA about the protein induces the formation of a positive 
supercoil as demonstrated by the fact that addition of ligase 
to a complex of gyrase and nicked circular DNA followed by 
deproteination resulted in an increase in linking number 
(17). Scanning electron microscopic studies have formed the 
basis for a model of the gyrase-DNA complex in which subunit 
A interacts with the cleavage site and the central 40 bp 
protected region. Surrounding the A subunits, the B subunits 
interact predominantly with the flanking sequences (13). 
The various activities required for this complicated 
reaction are most easily considered separately. 
1. Supercoiling DNA gyrase is responsible for maintaining 
cellular DNA in a negatively supercoiled state, requiring ATP 
and Mg++ to do so. The reaction is highly processive since 
after addition of relaxed DNA only supercoiled DNA is ob-
served on agarose gel electrophoresis, no intermediates are 
seen (16). Each gyrase molecule introduces about 100 super-
coils per minute under standard conditions (2). 2'dATP will 
substitute for ATP but at increased KM; no other nucleotide 
triphosphate will stimulate supercoiling. Addition of ADPNP 
to gyrase and relaxed DNA results in the introduction of 1.4 
supercoils per enzyme and then inhibition of further super-
coiling, indicating ADPNP causes one round of supercoiling, 
and implying that hydrolysis of ATP occurs after each round 
of supercoiling (16). 
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2. Relaxation In the absence of ATP, gyrase catalyzes the 
relaxation of negatively supercoiled DNA at a rate approxi-
mately 20-40 times slower than the forward reaction. The 
relaxation is not inhibited by novobiocin or coumermycin but 
is inhibited by oxolinic acid (23). Topoisomerase II', a 
form of gyrase containing a fragment of subunit B in place of 
B is able to catalyze the relaxation of positively super-
coiled DNA but is unable to introduce negative supercoils, 
results explained by the loss of a domain of the B subunit 
that is responsible for energy transduction (10,22). 
3. Double strand breakage Addition of oxolinic or nalidixic 
acid to gyrase and duplex DNA followed by treatment with SOS 
results in breakage of the duplex strand and covalent associ-
ation of gyrase subunit A to the 5 1 ends of the DNA via a 
phosphotyrosine bond (15). Gyrase makes a staggered cut 
leaving four base 5' overhangs. The frequency of cleavage 
and the pattern of fragments generated is changed by addition 
of ATP or ADPNP . This change is due to a conformational 
change of the enzyme on binding of ATP that alters the pro-
portion of enzyme molecules that cleave at their binding 
position (23). Gyrase, unlike restriction endonucleases, 
does not cleave at only one defined sequence. Much work has 
been directed to determining what features of the DNA 
sequence are recognized by gyrase. Examination of in vivo 
cleavage sites on addition of oxolinic acid has revealed the 
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consensus sequence, 
5'-RNNNRNRT/GRYCTYNYNYNGNY-3 1 , 
where N is any nucleotide, R is a purine and Y is a pyrimi-
dine. Cleavage occurred at the line (24). Mutagenesis of a 
strong cleavage site on pBR322 has identified some point 
mutations near the cleavage site that either reduce or abo-
lish cleavage (25). 
4. ATPase Gyrase catalyzes the hydrolysis of ATP to ADP and 
Pi in the presence of DNA with a KM of about 0.3 mM. The 
hydrolysis is stimulated much more strongly by duplex than by 
single strand DNA (3). ATPase activity is inhibited by novo-
biocin and coumermycin, evidence that the B subunit is res-
ponsible for ATPase activity (16). In the presence of urea 
or on heating the basal ATPase activity of the B subunit is 
substantially and stably increased, suggesting a conforma-
tional change that mimics the effect of binding to DNA. 
Addition of subunit A to activated subunit B had little ef-
fect on ATPase activity (22). 
5. Formation and Resolution of catenated and knotted DNA 
Gyrase catalyzes the formation of catenanes and knotted DNA 
under conditions of high DNA concentration and low ionic 
strength which serve to aggregate the DNA, reactions that 
implicitly require a double strand breaking of closed cir-
cular DNA. Gyrase can also relax knots and uncatenate DNA 
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under normal reaction conditions (3). 
The diverse reactions catalyzed by gyrase have been 
incorporated into several mechanistic models. In one model 
(27), gyrase binds DNA at specific sites and cleaves both 
strands. DNA adjacent to the cleavage site wraps around the 
enzyme in a positive supercoil. ATP binds, causing a confor-
mational change that both separates the strands and drives 
the wrapped DNA through the opening, decreasing the linking 
number by two. Hydrolysis of the bound ATP and release of 
ADP and Pi allow the enzyme to revert to its original con-
formation. That the hydrolysis follows strand passage is 
suggested by the experiments with ADPNP which allows one 
round of supercoiling. This model requires the ends of the 
DNA not rotate relative to one another. Therefore the two 
halves of the enzyme-DNA complex must remain in contact while 
the gap between the ends of the DNA is open. Contact between 
the B subunits during this phase of the reaction scheme is 
proposed. Formation of catenanes can be included in the 
model as transport of a different closed circular DNA mole-
cule. Relaxation of negatively supercoiled DNA in the ab-
sence of ATP could occur if DNA binds in the opposite sense 
and the duplex strand is transported in the opposite direc-
tion. A variation of this model requires that the positive 
supercoiling of the DNA bound to the enzyme not change but 
that a duplex strand be driven from outside the bound loop to 
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the inside (13). The sign inversion model proposes that 
gyrase binds two segments of DNA such that the binding causes 
the formation of a positively supercoiled node in one part of 
the ccDNA and a negative node in the remaining part (3). 
Strand breakage, followed by directional passage of one 
strand through the break converts the positive node to a neg-
ative one. 
Experimental Design and Methods 
General 
~ coli gyrase subunits A and B will be purified separ-
ately using the available plasmids pDH24 and pMK461. Plasmid 
pDH24, which carries the gyrA gene under control of the tac 
promoter, is maintained in a laciq strain, ~ coli RB968, and 
overproduction is initiated by addition of ITPG. Protein 
from an llL growth is precipitated with polymin P, resus-
pended, and precipitated again with ammonium sulfate. Resus-
pended protein is chromatographed on DEAE-cellulose and then 
on heparin-Sepharose to yield >95% pure gyrA. Plasmid pMK461 
directs the overproduction of gyrB, using a tempera-ture 
sensitive repressor. Protein from an llL growth is 
precipitated with ammonium sulfate followed by chromatography 
on DEAE-cellulose. Affinity chromatography on novobiocin-
Sepharose in which gyrB is eluted with ATP at low ionic 
strength yields 80% pure gyrB. Further purification by 
sizing gel chromatography gives essentially pure gyrB. A 
strong gyrase cleavage site is contained on a 211 bp fragment 
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of the available plasmid pDH51, which can be excised by di-
gestion with HindIII and purified by agarose gel electrophor-
esis. 
1. Investigation of the requirement for free sulfhydryls 
Reaction of gyrase tetramers and DNA with N-ethylmale-
imide {NEM) prevented the retention of the complex on a 
filter binding assay {28). Addition of p-chloromercuriphen-
ylsulfonic acid or NEM to gyrase completely inactivated both 
the ATPase and supercoiling activities {29). A thorough 
investigation of the apparent requirement for free sulfhyd-
ryls in gyrase may lead to identification of active sites and 
a better understanding of the mechanism of the enzyme. 
The first step will be to determine if one or both of 
the subunits is susceptible to inactivation by sulfhydryl 
reagents. Reaction of each subunit separately followed by 
recombination with unreacted complemetary subunit and as-
saying will determine if one or both subunits are reactive. 
Protection against reaction by sulfhydryl reagents using all 
the various ligands will be attempted, including ATP and its 
analogs, ADP, Pi, linear DNA of various lengths and the vari-
ous antibiotics. Protection experiments will be carried out 
on subunits individually and on the whole tetramer. Inactiv-
ation by a number of different sulfhydryl reagents will be 
carried out since differences in the charge of the reagent 
and the polarity of the site of reaction can lead to dif-
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ferences in the rate of inactivation. The ability of reacted 
subunits to reform the tetramer can be detected by cross-
linking experiments. Quantitation of the number of reactive 
cysteines will be carried out using either commercially 
available radioactive sulfhydryl reagents such as iodoacet-
amide or using the spectrophotometric reagent, DTNB. 
There is ample precedent for the involvement of cys-
teines in the active sites of ATPases. Brain hexokinase 
(30), Na+,:r<+-activated ATPase (31), phosphofructokinase (32), 
and aspartokinase L-homoserine dehydrogenase (33) have been 
shown to contain essential cysteines in the ATPase site. 
Thus, it is reasonable to suppose that gyrB may contain 
cysteines in its ATPase site. Affinity labeling of the 
ATPase sites of gyrB will be attempted using one or more of 
the available ATP affinity reagents including 8-azidoATP, 
fluorosulfonyl benzoyl adenosine, and 6-mercapto ribofuran-
osyl triphosphate (SHTP). SHTP has been shown to inactivate 
the enyzmes mentioned above by forming a disulfide bond with 
the cysteines of the ATPase site. The sequence of ~ coli 
DNA gyrase has been determined and shows five cysteines per B 
subunit (12). Two of the five cysteines are conserved in the 
gyrB subunit of ~ subtilis, making it likely one or both of 
these cysteines are involved in the ATPase site. Digestion 
of radiolabeled gyrB subunit by proteases or CNBr will be 
followed by isolation of labeled fragments by FPLC or HPLC. 
The labeled fragments will then be sequenced by automated 
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Edman degradation to localize them in the known gyrB 
sequence. A complication to be considered may arise if two 
cysteines are present in the active site. Loss of the cova-
lent label may occur due to displacement of the label from 
one cysteine by the second cysteine forming a disulfide bond, 
as has been observed in rabbit muscle pyruvate kinase (34). 
2. Investigations of the ATPase activity of gyrase 
Analogies have been drawn between the introduction of 
supercoils by gyrase and catalysis by enzymes involved in 
muscle contraction, protein synthesis, and oxidative phos-
phorylation (3). All four systems are proposed to undergo 
cyclical conformational changes driven by the hydrolysis of 
ATP. Experiments designed to test the validity of the anal-
ogy and to measure rates of individual steps of the proposed 
mechanism will be carried out. 
The reversibility of hydrolysis of ATP has been shown 
for isolated chloroplast coupling factor 1, demonstrating 
that proton-motive force is not implicitly required for ATP 
synthesis (35). This was accomplished using labeled phos-
phate, (32P)Pi, in the medium. (~-32PJATP was formed and 
detected by TLC and the ability of hexokinase to utilize the 
synthesized ATP to phosphorylate glucose. Similar experi-
ments will be carried out with gyrase. If gyrase acts as a 
conduit between the high energy of ATP and the high energy of 
supercoiled DNA, incubation of gyrase with ADP, (32 P)Pi, and 
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negatively supercoiled DNA should lead to the relaxation of 
the DNA and the formation of [~-32P]ATP. Control experiments 
with linear duplex DNA and without DNA will determine if ATP 
formation is dependent on negative supercoiling. The micros-
copic rate constants for ATP formation and hydrolysis may be 
measured by adding 32pi after formation of enzyme bound ATP 
with cold Pi and measuring the rate of label incorporation. 
This will also demonstrate enzyme bound ATP isin equilibrium 
with medium Pi· ATP may be formed on gyrase and then rapidly 
hydrolyzed, resulting in a futile cycle. This could be 
detected by carrying out the experiment with 180-water, as 
described below. 
When the reversibility of ATP hydrolysis has been demon-
strated during the relaxation of supercoiled DNA it will be 
interesting and informative to observe the reversibility of 
ATP hydrolysis during the forward, supercoiling reaction. A 
great deal of information regarding steps of the hydrolysis 
and synthesis of ATP by several ATPases has been gained by 
analyzing the extent of exchange of oxygen between water and 
phosphate. Analysis of the amount of 180 incorporated into 
Pi from 180-water, as determined by mass spectrometry over a 
wide range of ATP concentrations during the hydrolysis of ATP 
by Fl-ATPase showed that at low ATP concentrations almost all 
four oxygens were derived from water indicating nearly infin-
ite reversal of hydrolysis. At high ATP concentrations only 
one 180 was incorporated in each Pi· These results were in-
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terpreted as indicating cooperativity between alternating 
ATPase sites (36). The release of ADP from one ATPase site 
required the binding of ATP at another ATPase site. Cooper-
ativity between the two gyrB ATPase sites will be examined 
using the incorporation of 180 from water into Pi· The ex-
tent of 180 incorporation into Pi using various forms of DNA 
as cofactors, including closed circular DNA, linear DNA of 
various lengths and no DNA with gyrase tetramers and the B 
subunit alone over a wide range of ATP concentraitons will be 
determined. Comparisons of the extent of 180 incorporation 
and the distribution of 180-containing Pi species may indi-
cate differences in the rate of release of bound ADP under 
different conditions. The ratio of gyrase to cofactor DNA 
will be maintained at a low value to ensure on average one or 
a few gyrase tetramers per DNA molecule to prevent false 
cooperative effects due to nearest neighbor interactions on a 
single DNA molecule (37). 
3. Protein-DNA crosslinking 
Electron microscopy and patterns from DNase I foot-
printing studies have provided information on which a model 
of the gyrase tetramer-DNA complex has been based (13). To 
test the model and to refine further details of interaction 
between the enzyme and its DNA substrate, protein-DNA cross-
linking studies will be carried out. 
Two general approaches will be made. The first involves 
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the use of the bifunctional protein-DNA crosslinking reagent 
HSP, which contains a protein-specific moiety, succinate, 
covalently linked to the photoactivatable DNA-specific group, 
psoralen (40). The second approach will make use of 5-azido 
UTP which can be incorporated into the DNA substrate in place 
of the T of the TG doublet that is the site of cleavage by 
gyrase (39). 
HSP has been used to study the interactions between 
phage capsid and phage DNA (38). The general method used was 
addition of HSP to protein in the dark followed by removal of 
unreacted HSP. The solution is irradiated at 340-380 nm to 
form psoralen-DNA crosslinks, followed by exhaustive depro-
teination with proteinase K. The positions of the psoralen 
crosslinks are determined by denaturing in alkali and rapid 
separation of single strands from souble strands by agarose 
gel electrophoresis. The psoralen-crosslinked DNA renatures 
more rapidly than the denatured single stranded DNA and runs 
more slowly during electrophoresis. Gyrase subunits will be 
reacted separately with HSP, synthesized as described (40), 
and recombined with the unreacted complementary subunit 
followed by addition of a linear duplex DNA and photo-
lysis. The complex will then be deproteinated by treatment 
with proteinase K. Psoralen-crosslinked DNA will be separ-
ated from noncrosslinked DNA by the alkali-agarose gel 
system. Restriction endonuclease digestion analysis of the 
crosslinked DNA and comparison of the double strand fragments 
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isolated from a second denaturing agarose gel with size 
standards should allow localization of the positions of the 
psoralen crosslinks. HSP-treated gyrase B subunit should 
cause psoralen crosslinks predominately in the flanking 
regions of the DNA substrate and HSP-treated gyrase A subunit 
should cause crosslinking in the central, protected region of 
the DNA substrate. It will be necessary to treat the sub-
units with HSP under a variety of conditions of differing 
ratios of reagent to subunit and reaction times to ensure the 
least amount of perturbation of the structure of the gyrase-
DNA complex. 
The second approach to protein-DNA crosslinking, which 
may be less perturbative than the use of HSP, involves the 
use of 5-azido UTP, a photoreactive analog of UTP, that can 
be incorporated into linear duplex DNA by DNA polymerase I 
(39). Radiolabeled 5-azido UTP, synthesized as described, 
will be added in place of the T of the TG doublet that is 
the recognition sequence for DNA cleavage. Incorporation of 
5-azido UTP in place of T-990 of the major gyrase cleavage 
site on pBR322 may be accomplished using synthetic oligo-
nucleotides. The 410 bp SphI to NruI restriction fragment 
from pBR322 can be isolated by agarose gel electrophoresis. 
The isolated fragment will be ligated to synthetic oligonuc-
leotides encoding a duplex strand with one NruI-compatible 
end and extending up to T-990 of the TG doublet of the major 
site of cleavage by gyrase with a 4 base 5 1 overhang on the 
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opposite strand. Addition of 5-azido UTP and Pol I will add 
5-azido U in place of T-990. Subsequent ligation of a second 
set of oligonucleotides containing a 3 base 5 1 overhang com-
patible with the gyrase cleavage site will generate a linear 
substrate containing 5-azido U in place of T-990. Since some 
sequence specificity at this site exists it is reasonable to 
assume specific protein-DNA contacts are made. Photolysis of 
the gyrase DNA complex should lead to covalent linkage be-
tween subunit A and DNA. Extensive DNase I treatment fol-
lowed by separation of gyrase subunits by SOS-PAGE and auto-
radiography should confirm that the A subunit contains the 
label. Isolation by FPLC or HPLC of labeled protein frag-
ments generated by proteolysis and sequencing of those frag-
ments by automated Edman degradation will identify the resi-
due ( s) that contact the critical T. Differences in protein-
DNA linkage before and after induction of cleavage by addi-
tion of oxolinic acid will be examined. 
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Proposition 2 
Further Mutagenic Studies of 
B-Lactamase 
207 
The advent of site-directed mutagenesis has given 
biochemists a new tool for deciphering the complex relation-
ships between the structure of a protein and its function 
(1,2). Prior to the development of this technique only 
fortuitous discovery of random mutants allowed comparisons 
between the wild-type and mutant to discern the role of the 
varying amino acid. With site-directed mutagenesis the 
intelligent design of altered enzymes is possible to provide 
information on the mechanism of the enzyme, to alter its 
physical behavior, or to create new activities. 
Recent improvements in mutagenic techniques make possi-
ble the production of large numbers of structural variants at 
one or more positions of the protein's primary sequence sim-
ultaneously (3,4). Practicality requires a preliminary 
screen to select those mutants having the desired new activ-
ity or altered function from among the large number of var-
iants generated. The existence of a phenotypic screen for 
the activity of B-lactamase makes it a good candidate for 
site-directed mutagenesis. 
B-lactamase catalyzes the hydrolysis of penam and cephem 
antibiotics (5). These antibiotics act to prevent the bio-
synthesis of the bacterial cell wall by binding, essentially 
irreversibly, to the enzymes responsible for the construction 
of peptidoglycan (6). B-lactamase confers resistance by hy-
drolyzing the amide bond of the B-lactam ring rendering the 
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antibiotic incapable of acylating its target proteins. Ev-
idence exists that B-lactamase operates through the nucle-
ophilic attack of an active site serine on the carbonyl of 
the B-lactam ring to generate an acyl-enzyme intermediate, 
which then undergoes hydrolysis. B-lactamases have been 
ordered into three general classes based on substrate 
specificities and physical characteristics. Class A B-lacta-
mases hydrolyze penams at higher efficiency than cephems, 
have molecular weights of about 29 kdaltons, and show signif-
icant sequence homologies. The Class B enzyme is a zinc-con-
taining lactamase from ~ cereus. The Class C enzymes have 
molecular weights of approximately 39 kdatons and hydrolyze 
cephems at higher efficiency than penams (7). 
structural information about Class A B-lactamases exists 
in the form of primary sequence comparisons (7) as shown 
below and an x-ray crystal structure of the enzyme from ~ 
licheniformis, resolved to 6 A (8) (shown in Chapter 4, 
Figure la of this work) . 
65 70 
h aureus PCl k RF a y a S T s K a 
~ licheniformis 749/c e R F a f a s T i K a 
~ cereus 569/H g R F a f a s T y K a 
~ coli RTEM e R F p m m s T f K v 
Comparisons of the rest of the sequences reveal these four 
Class A B-lactamases are strictly homologous in 20% of their 
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residues but maintain homology by type in a much higher 
percentage of positions. Mutagenic studies attempted to date 
have concentrated on the strictly conserved residues about 
the active site serine (Ser70). The active site serine has 
been converted to cysteine (9) and threonine (10), the former 
mutant maintaining about 1% of the activity of the wildtype 
and the latter being completely inactive. The adjacent 
threonine (Thr71) has been replaced by the other nineteen 
amino acids. All mutants except Thr71-->Asp, Tyr, Trp, Lys, 
or Arg are able to confer resistance to cells to penam anti-
biotics although all mutants were of reduced thermal stabil-
ity compared to the wild-type enzyme (3). The saturation of 
lysine 73 was described in this work. The extension of these 
saturation mutagenic techniques to more than one residue 
simultaneously has been proposed (11). Saturating two res-
idues at the same time would require the generation of four 
hundred different proteins, making location of all four 
hundred mutants by sequencing individual colonies prohibi-
tively time-consuming. Initial screening for the desired 
function, resistance to ampicillin, will reduce the number of 
colonies to be sequenced. If a specific mutant is desired 
and not found during the sequencing of the active colonies, 
the mutant may either be located by colony screening using a 
specifically designed oligonucleotide probe or it may be 
constructed separately. Since not all mutants will be 
sequenced it is important to establish that in all probabil-
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ity all possible permutations have been screened. Thus, the 
synthetic oligonucleotides should contain an even mixture of 
all four bases at the first two positions of the mixed codons 
and of G and C at the third position to ensure the represen-
tation of all 1024 codons generated within a reasonable 
number of transformants. Zon, et al (12), have shown that 
even mixtures of oligonucleotides are possible during simple 
competitive couplings if fresh phosphoramidites are used. 
The highly conserved diad, Arg-Phe, at positions 65 and 
66 of the RTEM B-lactamase is a promising choice for two-site 
saturation mutagenesis. Both amino acids have quite similar 
substitutes, lysine and tyrosine, respectively. It will be 
interesting to see if these two amino acids can substitute 
for the wild-type sequence and if the possible permutations 
are also phenotypically active. Phe66 is also conserved in 
Class c B-lactamases although Arg65 is not. The possibility 
that Phe66 contributes to the binding energy of the enzyme 
substrate complex by favorable interactions with the aromatic 
side chain substituents may be explored by measuring the 
Michaelis-Menten parameters for substrates with and without 
aromatic side chains, for instance, benzylpenicillin and 6-
amino penicillanic acid, and comparing the values of KM with 
those of the wildtype enzyme. The codons for these two 
residues lie between convenient existing restriction sites 
allowing easy construction by cassette mutagenesis. 
The extension of saturation mutagenesis to a site that 
211 
is not strictly conserved but is conserved by type is also 
proposed. Several candidates close to the active site serine 
exist such as Phe60. Creation of a unique restriction site 
5 1 to the codon for Phe60 would be required for cassette 
mutagenesis. It may be possible to acquire information about 
the reasons behind the greater flexibility of this position. 
Another position for mutagenesis is Phe72 which lies between 
the critical active site residues. This site does not appear 
to be conserved at all. Saturation mutagenesis of this site 
will determine which amino acids may substitute at position 
72 without disturbing the spatial relationship between the 
essential active site residues, serine and lysine. 
Further studies with existing mutants at positions 71 
and 73 of B-lactamase are proposed. The binding of substrate 
to RTEM-1 B-lactamase produces a conformational change in the 
enzyme as judged by differences in the susceptibility to 
activity loss by proteolysis. Under conditions where in the 
absence of substrate B-lactamase was inactivated by proteo-
lysis by Pronase with a half-life of 7 to 9 minutes, addition 
of either benzylpenicillin or cephalothin increased the 
half-life to greater than 60 minutes. Addition of oxacillin 
under the same conditions caused a reduction of the half-life 
of residual activity to less than one minute (13). The 
importance of this apparent conformational change to cata-
lysis and the interactions between substrate and residues of 
the protein that mediate it are not clear. The importance of 
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Lys73 in the substrate induced conformational change may be 
determined by examining the proteolytic susceptibility of 
mutants at position 73, particularly Lys73-->Arg since it is 
the most conservative change. Any change in the half-life of 
residual activity or absence of a change in the half-life on 
addition of substrates would indicate the participation of 
Lys73 in mediating the apparent conformational change. Since 
mutants at Lys73 are severely defective in catalysis, if any 
change in the substrate mediated conformational change is 
detected, the correlation may indicate the conformational 
change is important in achieving the maximal turnover rate. 
If differences are detected it may be interesting to examine 
the possibility of substrate induced hysteresis, an effect 
not normally associated with RTEM B-lactamases but which has 
been observed with other Class A enzymes. 
Adjusting the dependence of enzymic activity on pH is 
one objective of protein engineering. As discussed in 
Chapter 2 of this work, substitution of cysteine for Thr71 
caused a dramatic decrease in enzyme activity at alkaline 
pH. The decrease is probably due to the development of 
anionic character in the vicinity of the active site serine 
nucleophile. A complementary experiment would be to examine 
the pH activity profile of the mutant Thr71-->His. The side 
chain of histidine has a pKa of 6.0. Thus, below pH 6 the 
side chain of the amino acid adjacent to the active site 
nucleophile would develop positive charge. The variation in 
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kcat and KM at lower pH would give information on the influ-
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Proposition 3 
Mutagenesis of Triosephosphate 
Isomerase 
216 
Triose phosphate isomerase {TIM) catalyzes the inter-
conversion of glyceraldehyde-3-phosphate {GAP) and dihydroxy-
acetone phosphate {DHAP), which are generated during glycol-
ysis by the splitting of fructose-1,6-diphosphate by aldol-
ase. The interconversion is necessary since the next step in 
glycolysis converts GAP to 1,3-diphosphoglycerate, so TIM 
serves to draw DHAP into the useable aldehyde pool. The 
mechanism of the interconversion by TIM involves the use of 
general acid-base catalysis as shown below. General base 
abstraction of the 1-pro-R proton of DHAP by Glul65 of the 
enzyme from chicken muscle and donation of a proton from an 
as yet unidentified general acid (either Lysl3 or His95 or 
both) leads to formation of the intermediate enediol. The 
following step is the donation of a proton to c-2 by the 
conjugate acid of the general base and abstraction of the 
hydroxyl proton at C-1 by the conjugate base of the general 
acid to give enzyme-bound GAP (1,2). 
~ ..o-w. ~H.:I' 
,r "\:!\;../~ .;~\ ~} 
c=o-· ~ 'V c-o,. 
!.,-® ~ ~ 
The energetics of catalysis by TIM have been examined in 
detail, by isotope exchange experiments. The establishment 
of general base participation was shown by the small but 
measurable tritium transfer from [l(R)-3H]dihydroxyacetone-3-
phosphate to c-2 of product GAP (3). The incorporation of 3H 
from 3H2o into product GAP and into substrate DHAP during the 
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forward (DHAP-->GAP) reaction was examined, under conditions 
where released product was trapped by reduction to glycerol 
phosphate by NADH dehydrogenase (4). The discrimination 
against tritium incorporation into product as measured by the 
ratio of the specific activity of 3H2o to glycerol phosphate 
was 1.3, a value too low to represent a primary kinetic 
isotope effect. Therefore, it was concluded that the inter-
mediate enediol and the enzyme bound product and substrate 
are in rapid equilibrium and the rate-determining step of the 
forward reaction is product release. The rate of the in-
crease of the specific activity of the substrate DHAP showed 
the enediol reverses to enzyme-bound substrate about one 
third as rapidly as it goes on to product GAP. The reverse 
reaction (GAP-->DHAP) had a primary kinetic isotope effect of 
8 against tritium incorporation into DHAP from 3H2o under 
conditions where the DHAP was trapped by oxidation to 3-phos-
phoglycerate. Under these conditions release of substrate is 
not rate-determining and the intermediates were not in rapid 
equilibrium. Partitioning experiments allowed the determin-
ation of the relative rates of the individual reactions. A 
free energy diagram incorporating the results of the isotope 
exchange experiments has been developed. The rate deter-
mining step of the reverse reaction, the association of GAP 
and TIM is 3xlo8 M-lsec-1, a value that approaches the 
diffusion limit. Therefore, TIM is thought to have reached 
the end of its evolutionary development since increasing the 
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rate of any of the chemical steps of the catalytic mechanism 
cannot increase the overall rate of catalysis (5). 
A crystal structure of TIM from chicken muscle has been 
solved to 2.5 A resolution (6) and the structure of TIM from 
yeast is known to 1.9 A without substrate (7) and to 3.5 A 
with substrate bound (8). A schematic representation of 
active site residues is shown below (taken from ref. 10). 
Because of the detailed existing knowledge of the mechanism 
and energetics of catalysis by TIM and the high quality of 
the structural information available, TIM is an excellent 
system for study by_ site-directed mutagenesis. 
A mutant of TIM, Glul65-->Asp, has been constructed by 
oligonucleotide-directed mutagenesis. This mutant removes 
one methylene group from the active site general base and 
decreases the rate of catalysis 1000-fold (9). A detailed 
investigation of the changes in the rates of individual steps 
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in the catalytic mechanism has been carried out. The mutant 
was first shown to catalyze the interconversion of DHAP and 
GAP by general acid-base catalysis as does the wildtype en-
zyme and not by indirect catalysis by a water molecule. The 
proof consisted of identical stoichiometries of inactiv-
ation by the affinity reagent bromohydroxyacetone phosphate 
and identical solvent D20 effects. An increase of 4 kcal/mol 
in the transition state energies of the reactions converting 
the enediol intermediate to enzyme-bound DHAP and to enzyme-
bound GAP was calculated (10). 
Catalysis by TIM has an electrophilic general acid 
component. The role of the general acid is to assist in the 
polarization of the carbonyl group of DHAP. Proof of the 
existence of this polarization comes from experiments that 
show the rate of reduction of the carbonyl of DHAP by 
borohydride is 8 times faster when the DHAP is bound by the 
enzyme than when it is free in solution (11), and the fact 
that FT-IR shows the carbonyl stretching frequency of enzyme-
bound DHAP is 19 cm-1 less than free DHAP (12). The unambig-
uous assignment of the electrophilic component of catalysis 
to a specific amino acid residue is not possible based on 
existing structural information. However the most likely 
candidates for the general acid catalyst are the side chains 
of either Lysl3 or His95 or both, as shown in the figure 
above. site-specific mutagenesis of these two residues 
should both determine the relative contributions of these two 
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residues to catalysis and the importance of the general acid 
to catalysis by TIM. 
Lysl3 and His95 will be converted separately and to-
gether into alanine(s) which removes the possibility of gen-
eral acid contributions to catalysis from these residues. 
Alanine is chosen because it represents the least disruptive 
mutation possible, substituting an H for the imidazole of the 
histidine and for (CH2)3NH3+ of the lysine. It may also be 
interesting to invert Lysl3 and His95 to create a double 
mutant (Lys95,Hisl3). The mutation Lysl3-->Arg will also be 
constructed as it is the most conservative mutation possible. 
Oligonucleotide-directed mutagenesis will be carried out 
using the gapped plasmid method on a 1046 bp NcoI fragment 
encoding the chicken TIM gene (9). The following mutagenic 
oligonucleotide probes will be synthesized using the phos-
phoramidi te chemistry (13), 
Lysl3-->Ala 
** 5 1 GGC AAC GCG AAG ATG 3 1 
His95-->Ala 
** 5 1 CTG GGC GCC TCA GAG 3 1 
(Asterisks denote the mismatched bases.) The mutagenic probes 
made radioactive by kinasing using standard procedures (14), 
and screening for the desired mutations will be carried out 
as described (15). To create the double mutant, Lysl3-->Ala, 
His95-->Ala, the same mutagenic procedure can be carried out 
on the single mutant Lysl3-->Ala using the His95-->Ala muta-
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genie probe. Double mutants will be identified by screening 
with both probes and by Maxam-Gilbert sequencing. Expression 
of mutant protein will be carried out in ~ coli, using 
plasmid pXl (10). Mutant TIM protein will be purified accor-
ding to published procedures (10). Crystallization of the 
mutant proteins and comparison of the structures by differ-
ence mapping with the known crystal structure of the enzyme 
from chicken muscle is a relatively rapid procedure and will 
determine if any gross structural changes accompany the in-
troduction of the mutations. 
Measurement of the Michealis-Menten parameters and 
analysis of the changes in the energetics of the catalytic 
mechanism will be carried out using the same kinds of isotope 
partitioning experiments described earlier. An interesting 
possibility is that both residues His95 and Lysl3 contribute 
to general acid catalysis. The -amino group of the lysine 
side chain may contribute a proton to the C-2 carbonyl of 
DHAP while the imidazole ring of His95 accepts the hydroxyl 
proton of c-1. If this double participation exists then both 
mutations will show an increased energy of activation for 
the formation of the enediol. In contrast if only one of the 
two residues is primarily responsible for the electrophilic 
component of catalysis then only one of the two mutants will 
show a substantial decrease in the reaction rate and an 
increase in the activation energy for enediol formation. If 
there is no change in the energetics of either singly mutated 
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enzyme the cause may be the ability of one of the residues to 
substitute for the other. In this case the double mutation 
should show a substantial change in the reaction energetics. 
If there is no electrophilic component of catalysis then none 
of the mutants should show major changes in the reaction rate 
or energetics. If perturbations introduced by the Lysl3--> 
Ala mutation leave the mutant completely inactive, it may be 
interesting to convert Lysl3 to cysteine and react the 
resulting mutant with ethylenimine as described in Chapte 4 
of this work. Slight differences in bond distances and 
angles may be reflected in the reaction energy profile. 
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Kinetic studies of the T4 Replication System 
226 
The rapid, efficient replication of prokaryotic DNA with 
high fidelity is carried out by multicomponent protein sys-
tems which catalyze a complex series of reactions. In gen-
eral, these reactions include initiation of replication at 
specific sites on the chromosome by nicking of one strand or 
by unwinding of the DNA helix, followed by synthesis of an 
RNA primer. The replication extends from the primer in the 
3 1 direction (of the growing strand) copied from the leading 
strand and as the helix is unwound the lagging strand is 
copied discontinuously (1). Fidelity is believed to be main-
tained by a continuous 3 1 -5 1 exonuclease activity of the 
polymerase which acts to edit out incorrectly placed bases. 
All of the components necessary for the replication of bac-
teriophage T4 DNA have been identified. 
The products of seven genes of the bacteriophage T4 are 
necessary for in vivo replication of its DNA; genes 32, 41, 
44, 45, 61 and 62 (2,3). Gene 41 and 61 proteins are both 
involved in the synthesis of the pentanucleotide primer, 
pppACN3 (4). The sigmoidal dependence of the activity of 
protein 41 on protein concentration suggests it forms oligo-
mers (5). Gene 32 protein is a single-strand DNA-binding 
protein that serves to destabilize secondary structures of 
self-complementary single stranded DNA and to prevent renat-
uration of melted duplex DNA . Gene 43 protein is the 110 
kdalton T4 DNA polymerase. It has a 3'-5' exonuclease act-
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ivity and can by itself catalyze the elongation of a primed 
template. However, the T4 polymerase will incorporate only a 
few nucleotides before dissociating from the template (6). 
The products of genes 44 and 62 copurify as an ATPase (7). 
Addition of the 44/62 and the gene 45 protein to the T4 poly-
merase caused an increase in the processivity of the reaction 
in a manner dependent on the hydrolysis of ATP (8). The ad-
dition of the 44/62 protein and the gene 45 protein also sti-
mulated the 3'-5' exonuclease activity of the T4 polymerase 
(9). These results have been interpreted as indicating the 
accessory proteins (gene 44/62 and 45 proteins) serve to hold 
the polymerase on the DNA template. A quantitative examina-
tion of the on and off rates of the T4 polymerase binding to 
its DNA template in the presence and absence of the accessory 
proteins can be made. 
The experimental design will follow an elegant series of 
experiments carried out on DNA polymerase I (Pol I) (10). 
The system used included a homopolymer of poly(dA) as tem-
plate, an oligomer of dT as the primer, and dTTP as sub-
strate. A preferential order of binding was established by 
isotope partitioning experiments. Pol I was incubated with 
[3H]dTTP to form the bound complex and then the template-
primer system and unlabeled TTP were added. The failure to 
detect incorporation of high specific activity dTTP into the 
template at short reaction times indicated the [ 3HJdTTP was 
released before the DNA bound to the enzyme. In a complemen-
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tary experiment, Pol I was preincubated with template-primer 
and then [3H]dTTP and an excess of denatured challenger DNA 
was added. The incorporation of [3H]dTTP into template DNA 
was indicative of a productive Pol I-template DNA complex, 
and analysis of the curvature of the incorporation of counts 
into DNA vs. reaction time allowed a direct measurement of 
the off rate of Pol I-template binding. Scatchard analysis 
of the same experiment at varying conentrations of template 
DNA allowed measurement of the intrinsic dissociation con-
stant of the Pol I-template DNA complex. These results dem-
onstrated a pref erred order of binding of Pol I to template 
and then to dTTP, consistent with the role of Pol I as an 
editing polymerase. The rate of association of the Pol !-
template complex was determined by calculation from the known 
dissociation rate and the known equlibrium constant of dis-
sociation and was also measured directly by the rate of in-
crease of light scattering. Similar experiments will be 
carried out using the T4 replication system. Rates of asso-
ciation and dissociation of T4 polymerase and template DNA 
will be measured in the presence and absence of the gene 
44/62 protein, the gene 45 protein, and ATP. If the acces-
sory proteins serve to anchor the T4 polymerase to its tem-
plate, then the rate of dissociation the polymerase in the 
presence of the accessory proteins should be less than in 
their absence. 
The increase in the processivity of T4 polymerase in the 
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presence of the accessory proteins could be due an increase 
in the rate of addition of bases to the template. Further 
experiments will determine if addition of the accessory pro-
teins to T4 polymerase causes any change in the kinetics of 
the polymerization reaction itself. An examination of the 
kinetics of incorporation of (3H]dTTP during the first turn-
over by Pol I was made using stopped-flow instrumentation and 
chemical quenching of the reaction by addition of EDTA. Bi-
phasic kinetics were observed and the curve shape was deter-
mined to be consistent with a mechanism containing two par-
tially rate-determining steps. These two steps were sug-
gested to be conformational changes of the enzyme that first 
allow hydrolysis of the bound dTTP and second cause the 
translocation of the enzyme to the next base on the DNA tem-
plate. Similar rapid kinetics experiments on the incorpor-
ation of the first dTTP into prebound DNA template and T4 
polymerase will be carried out in the presence and absence of 
accessory proteins and ATP. 
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Proposition 5 
Protein-Protein Interactions in the hin 
Recombinase System 
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Site-specific recombination systems have been isolated 
from several prokaryotes. These systems mediate specific DNA 
rearrangements that are involved in several important func-
tions, such as separation of chromosomes, regulation of gene 
expression and transposition. Four systems of varying com-
plexity have been characterized. The lox-ere system of bac-
teriophage Pl requires only two 34 bp recognition sequences 
and the ere gene product, a 35 kdalton protein (1). The 
lox-ere system is important in circularizing linear duplex Pl 
DNA on entering the host cell and in resolving dimers of Pl 
DNA formed during replication (2,3). The resolvase system 
operates on the Tn3 family of transposons. It requires a 
supercoiled DNA substrate containing three resolvase binding 
sites in a defined orientation (4,5). The att-Int system 
requires the involvement of a host protein in addition to a 
complex of four binding sites and the integrase, IHF, which 
is composed of two polypeptides of molecular weights 11 and 
9.5 kdaltons (6). 
The control of expression of the flagellin genes of 
Salmonella typhimurium is determined by hin recombinase, 
representative of the fourth type of system. The inversion 
of a 996 bp sequence of chromosomal DNA switches the position 
of a promoter for one flagellin gene and the repressor of a 
second flagellin gene. The DNA requirements for the inver-
sion are two 26 bp segments in an inverted configuration and 
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a 60 bp enhancer sequence that can increase the rate of 
inversion 150-fold (7). The proteins required for recombin-
ation include the hin protein, a 21 kdalton DNA binding 
protein and Factor II, a 12 kdalton protein which has been 
shown to bind the enhancer sequence. The presence of ~ coli 
histone-like protein HU also increases the rate of inversion, 
probably by binding nonspecif ically to the DNA and promoting 
bending of the DNA that helps bring together the two recom-
binational sites (8). Interestingly, the gene for the hin 
protein resides within the 996 bp inversion segment and shows 
40% homology to tnpR, the gene for Tn3 resolvase (9). The 
distance between the enhancer sequence and the proximal hin 
recognition site was varied and efffcient enhancement of the 
inversion rate was found to be invariant with distance beyond 
a minimum of about 100 bp (7). Hin and Factor II have been 
shown to bind independently to their respective binding sites 
(10). The orientation between the enhancer sequence and the 
proximal hin binding site, either between the two hin sites 
or on the outside, did not effect the enhancement of the 
inversion rate (7). 
The role of the host protein, Factor II, in increasing 
the rate of inversion is not well understood. One possibil-
ity that has been suggested (8) is that specific protein-pro-
tein interactions between Factor II bound to the enhancer 
sequence and hin recombinase bound to the distal hin site 
help to increase the rate of formation of the synaptic 
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complex which then undergoes inversion. Experiments designed 
to test this possibility and to detect Factor II-hin recom-
binase interactions will be carried out. 
To determine if tracking, the binding of one hin subunit 
to a hin site then diffusion of a second subunit along the 
DNA until the second site is found, is the basis of the 
baseline inversion rate in the absence of Factor II, the 
following experiment will be carried out. Catenanes will be 
made of pBR322 containing one hin site constructed by li-
gating into the Sal! site synthetic oligonucleotides encoding 
the 26 bp hin site with SalI compatible linkers on either 
end. The 60 bp enhancer sequence may be incorporated into 
any other single-cut restriction site in a similar fashion. 
The construction of catenanes by DNA gyrase has been des-
cribed as has the importance of tracking in the resolvase 
system (5). This technique of construction will allow the 
variation of the distance between the hin site and the enhan-
cer sequence. If hin recombinase tracks along its DNA sub-
strate, it will not jump to the sister plasmid and recognize 
the second hin site so no inversion will take place. If in-
version does take place it will lead to the formation of a 
single circular DNA molecule. Detection of inversion can be 
accomplished by digestion with any single cutting restriction 
endonuclease and subsequent agarose gel electrophoresis. In-
version and endonuclease digestion will give three DNA frag-
ments. Absence of inversion and endonuclease digestion will 
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give linearized plasmid. The effect of adding Factor II will 
be determined. If specific Factor II-hin recombinase inter-
actions exist they may cause hin recombinase to jump strands 
and catalyze inversion. 
The possibility of specific interactions between Factor 
II and hin recombinase will also be tested by crosslinking 
experiments, using the bifunctional crosslinking reagent 
dimethyl suberimidate. To determine the conditions under 
which the hin protein can form oligomers in the absence of 
DNA the concentration of hin protein will be varied using a 
constant concentration of crosslinker and vice versa. Anal-
ysis of crosslinked products will be carried out by SDS-PAGE 
and silver staining. When the conditions for hin protein 
oligomerization have been established the same experiment 
will be performed in the presence of plasmid DNA containing 
one or two hin sites. The same experiments will be carried 
out using Factor II. These experiments will determine if a 
limited number of protein molecules interact with each hin or 
enhancer site. 
When the conditions for hin-hin and Factor II-Factor II 
crosslinking have been established, the possibility of hin-
Factor II crosslinking will be explored. To determine the 
conditions under which hin and Factor II associate in the ab-
sence of DNA crosslinking will be attempted with various con-
centrations of hin holding the Factor II concentration con-
constant and vice versa. The effect of adding a DNA sub-
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strate containing binding sites for both hin and Factor II 
will be determined. Presumably, if direct association 
between hin and Factor II occurs, it should be possible to 
crosslink them in the presence of DNA containing both binding 
sites under conditions where they are not crosslinked in the 
absence of DNA substrate. The control reactions which in-
clude plasmid DNA which alternately has no hin or enhancer 
site will also be carried out to show that the detected in-
teractions between hin protein and Factor II depend on the 
presence of specific binding sites. Another control reaction 
would include plasmid DNA that has one hin site and the 
enhancer sequence separated by various distances. Since 
enhancement is prevented by placing the enhancer and the hin 
site at a distance of 48 bp it will be interesting to see if 
crosslinking is prevented by this arrangement. If the amount 
of hin-hin and Factor II-Factor II crosslinking is too great 
it may be possible to reduce it by binding Factor II to its 
enhancer site and then adding the crosslinker, followed by 
dialysis to remove excess crosslinker and addition of hin 
protein. To show that any detected interaction between hin 
and Factor II is specific and not induced by the crosslinking 
reagent, crosslinking between Factor II and ~ coli histone-
like protein HU will be attempted. If Factor II-hin protein 
interactions are specific, no crosslinking between Factor II 
and HU should be detected. 
If large numbers of hin subunits and Factor II are 
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crosslinked it may not be possible to distinguish complexes 
by SDS-PAGE gels since resolution of higher molecular weight 
complexes may be poor. However, useful information about the 
structure of crosslinked complexes of Factor II, hin protein, 
and DNA may come from electron microscopic studies. Obser-
vation of complexes between ~ coli DNA gyrase and its DNA 
substrate have led to the development of models for gyrase 
interaction with DNA (11). The use of DNA substrates with 
varying distances between the hin binding sites and the 
enhancer sequence may allow observation of looped structures 
proving the existence of specific interactions between hin 
protein and Factor II. 
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